var title_f14_37_14928="Congenital diaphragmatic hernia";
var content_f14_37_14928=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    This intubated newborn infant with the prenatal diagnosis of a left chest mass shows classic findings of a congenital diaphragmatic hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There are air-filled bowel loops in the left chest causing mass effect and mediastinal shift towards the right. The nasogastric tube terminates in the left thoracic stomach. The umbilical venous catheter takes an atypical course because the liver is partially herniated into the left chest.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeanne Chow, MD, and Children's Hospital Boston.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14928=[""].join("\n");
var outline_f14_37_14928=null;
var title_f14_37_14929="AML FAB M3V Microgran";
var content_f14_37_14929=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F61151&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F61151&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute promyelocytic leukemia (M3V)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 391px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blood smear from a patient with the microgranular promyelocytic variant of AML (FAB classification M3V). (Wright-Giemsa stain). The promyelocytes vary in size and degree of cytoplasmic basophilia. The cytoplasm contains abundant, fine, azurophilic granules; nuclei are markedly lobulated and invaginated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Brunning, RD, McKenna, RW. Tumors of the bone marrow. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 9, 1994, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14929=[""].join("\n");
var outline_f14_37_14929=null;
var title_f14_37_14930="Patient information: Chronic sinusitis (The Basics)";
var content_f14_37_14930=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/86637\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/62/10210\">",
"         Sinuses of the face",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?16/18/16674\">",
"         Patient information: Rinsing out your nose with salt water (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/53/17234\">",
"         Patient information: Sinusitis in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/13/37073\">",
"         Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/58/42915\">",
"         Patient information: Chronic rhinosinusitis (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Chronic sinusitis (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H554932357\">",
"      <span class=\"h1\">",
"       What is chronic sinusitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Chronic sinusitis is long-lasting form of sinusitis. Sinusitis is a condition that causes a stuffy nose, pain in the face, and discharge (mucus) from the nose.",
"     </p>",
"     <p>",
"      The sinuses are hollow areas in the bones of the face (",
"      <a class=\"graphic graphic_figure graphicRef75045 \" href=\"UTD.htm?9/62/10210\">",
"       figure 1",
"      </a>",
"      ). They have a thin lining that normally makes a small amount of mucus. When this lining gets infected, it swells and makes extra mucus.",
"     </p>",
"     <p>",
"      The most common type of sinusitis often happens after you catch a cold. It is also called &ldquo;acute sinusitis&rdquo; and usually gets better in 1 to 3 weeks. Chronic sinusitis lasts for at least 3 months. People with this condition often have very swollen sinuses. One or more sinus might get filled with infected mucus. Some people get abnormal growths inside their noses or sinuses, called &ldquo;polyps.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H554932391\">",
"      <span class=\"h1\">",
"       What are the symptoms of chronic sinusitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include having at least 2 of the following symptoms for at least 3 months:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Stuffy nose",
"       </li>",
"       <li>",
"        Yellow, green, or brown mucus that drips from the nose or down the back of the throat",
"       </li>",
"       <li>",
"        Pain, pressure, or &ldquo;fullness&rdquo; in the face",
"       </li>",
"       <li>",
"        Not being able to smell things as well as usual",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H554932406\">",
"      <span class=\"h1\">",
"       Are some people more likely to get chronic sinusitis than others?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You might be more likely to get chronic sinusitis if you have:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Allergies &ndash; Allergies to molds, cockroaches, dust mites (tiny insects found in dust), and animal dander (tiny flakes from animal fur, hair or skin) are most likely to cause sinus problems. (Things that cause allergies, such as pollen and mold, are called &ldquo;allergens.&rdquo;)",
"       </li>",
"       <li>",
"        Problems with your body&rsquo;s infection-fighting system (called the &ldquo;immune system&rdquo;) &ndash; These conditions are called &ldquo;autoimmune diseases.&rdquo;",
"       </li>",
"       <li>",
"        Frequent colds.",
"       </li>",
"       <li>",
"        An injury or deformity of the nose that makes it hard to drain mucus normally.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Breathing cigarette smoke might also makes you more likely to get chronic sinusitis.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H554932421\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse right away if you have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fever higher than 102.5&deg;F (39.2&deg;C)",
"       </li>",
"       <li>",
"        Sudden and severe pain in the face and head",
"       </li>",
"       <li>",
"        Trouble seeing or seeing double",
"       </li>",
"       <li>",
"        Swelling or redness around 1 or both eyes",
"       </li>",
"       <li>",
"        A very bad headache or stiff neck",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H554932436\">",
"      <span class=\"h1\">",
"       Are there tests for chronic sinusitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        CT scan or other imaging tests &ndash; Imaging tests create pictures of the inside of the sinuses.",
"       </li>",
"       <li>",
"        A test to look inside the sinuses &ndash; For this test, a doctor puts a thin tube with a camera on the end into the nose and up into the sinuses.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H554932451\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you smoke, quit. If you have allergies, talk to your doctor about how to better control your allergy symptoms.",
"     </p>",
"     <p>",
"      You can also rinse out your nose with salt water. This cleans the inside of your nose and washes allergens and mucus from the nose. Different devices can be used to rinse the nose.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H554932466\">",
"      <span class=\"h1\">",
"       How is chronic sinusitis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor might recommend different treatments, including:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Steroids &ndash; These medicines help to reduce swelling, mucus, and shrink polyps, if you have them. (They do not contain the same steroids that athletes take to build muscle.) They can be taken as sprays or drops that you put in your nose. You can also add steroid medicines to the salt water you use for rinsing out your nose. Your doctor also might prescribe steroid pills.",
"       </li>",
"       <li>",
"        Antibiotics &ndash; These are used to treat sinus infections, which sometimes happen when you have chronic sinusitis.",
"       </li>",
"       <li>",
"        Surgery &ndash; Some people with chronic sinusitis need surgery to reopen blocked nasal passages and remove polyps or mucus trapped in the nose. But this is usually done only in people who do not get better after trying medicines.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H554932481\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/53/17234?source=see_link\">",
"       Patient information: Sinusitis in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/18/16674?source=see_link\">",
"       Patient information: Rinsing out your nose with salt water (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/13/37073?source=see_link\">",
"       Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/58/42915?source=see_link\">",
"       Patient information: Chronic rhinosinusitis (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?14/37/14930?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86637 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-D86B8ADF8C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14930=[""].join("\n");
var outline_f14_37_14930=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H554932357\">",
"      What is chronic sinusitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H554932391\">",
"      What are the symptoms of chronic sinusitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H554932406\">",
"      Are some people more likely to get chronic sinusitis than others?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H554932421\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H554932436\">",
"      Are there tests for chronic sinusitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H554932451\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H554932466\">",
"      How is chronic sinusitis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H554932481\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/86637\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/62/10210\">",
"      Sinuses of the face",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/13/37073?source=related_link\">",
"      Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/58/42915?source=related_link\">",
"      Patient information: Chronic rhinosinusitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/18/16674?source=related_link\">",
"      Patient information: Rinsing out your nose with salt water (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/53/17234?source=related_link\">",
"      Patient information: Sinusitis in adults (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_37_14931="Anterior view of proximal humerus";
var content_f14_37_14931=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F71903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F71903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anterior view of proximal humerus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 429px; height: 430px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows pertinent neural and vascular structures that may be compromised by fractures of the proximal humerus. The supraspinatus muscle tendon attaches to the greater tuberosity of the humerus. The subscapularis tendon attaches at the lesser tuberosity. The bicipital tendon (not shown) courses in the groove between the tuberosities along with arterial branches of the anterior circumflex artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14931=[""].join("\n");
var outline_f14_37_14931=null;
var title_f14_37_14932="Magnesium salicylate: Drug information";
var content_f14_37_14932=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Magnesium salicylate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?17/16/17668?source=see_link\">",
"    see \"Magnesium salicylate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F191030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Doan's&reg; Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Keygesic [OTC];",
"     </li>",
"     <li>",
"      Momentum&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F191043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Salicylate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F191033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Relief of mild-to-moderate pain:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Doan's&reg; Extra Strength, Momentum&reg;: Two caplets every 6 hours as needed (maximum: 8 caplets/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Keygesic: One tablet every 4 hours as needed (maximum: 4 tablets/24 hours)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F191040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Relief of mild-to-moderate pain:",
"     </b>",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F191022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral, as tetrahydrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Doan's&reg; Extra Strength: 580 mg [equivalent to anhydrous magnesium salicylate 467.2 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Momentum&reg;: 580 mg [equivalent to anhydrous magnesium salicylate 467 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral [chelated]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Keygesic: 650 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F191015\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F191025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer with a full glass of water.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F191024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mild-to-moderate pain, fever, various inflammatory conditions; relief of pain and inflammation of rheumatoid arthritis and osteoarthritis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F3345281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to Aspirin monograph.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F3345279\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to magnesium salicylate, salicylates, other NSAIDs, or any component of the formulation; advanced chronic renal dysfunction; concomitant use with uricosuric agents",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     In patients &ge;65 years of age: Also contraindicated with a history of chronic salicylate use, carditis, chronic liver dysfunction",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F191018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Salicylate sensitivity: Patients with sensitivity to tartrazine dyes, nasal polyps, and asthma may have an increased risk of salicylate sensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tinnitus: Discontinue use if tinnitus or impaired hearing occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding disorders: Use with caution in patients with bleeding disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dehydration: Use with caution in patients with dehydration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ethanol use: Heavy ethanol use (&gt;3 drinks/day) can increase bleeding risks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal disease: Use with caution in patients with erosive gastritis or peptic ulcer.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment:",
"     <b>",
"      [U.S. Boxed Warning]: Use with caution in patients with hepatic impairment;",
"     </b>",
"     avoid in severe impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoprothrombinemia/vitamin K deficiency:",
"     <b>",
"      [U.S. Boxed Warning]: Use high doses with caution in patients with  hypoprothrombinemia and/or vitamin K deficiency.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; avoid use in severe impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: The lowest effective dose should be used in patients &ge;65 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Children and teenagers who have or are recovering from chickenpox or flu-like symptoms should not use this product. Changes in behavior (along with nausea and vomiting) may be an early sign of Reye's syndrome; patients should be instructed to contact their healthcare provider if these occur. Safety and efficacy have not been established in children &lt;12 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Surgical patients:",
"     <b>",
"      [U.S. Boxed Warning]: Use with caution prior to surgery;",
"     </b>",
"     surgical patients should avoid salicylates if possible, for 1-2 weeks prior to surgery, to reduce the risk of excessive bleeding.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F3345286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfacalcidol: May increase the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Magnesium Salts may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral magnesium salts within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcitriol: May increase the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: May enhance the adverse/toxic effect of Magnesium Salts. Magnesium Salts may enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Magnesium Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: Magnesium Salts may decrease the serum concentration of Eltrombopag.  Management: Separate administration of eltrombopag and any polyvalent cation (e.g., magnesium-containing products) by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Magnesium Salts may decrease the serum concentration of Mycophenolate.  Management: Separate doses of mycophenolate and oral magnesium salts. Monitor for reduced effects of mycophenolate if taken concomitant with oral magnesium salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents: Magnesium Salts may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Magnesium Salts may decrease the serum concentration of Phosphate Supplements.  Management: Administer oral phosphate supplements at least 1 hour before, or 2 hours after, oral magnesium salt administration.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Magnesium Salts may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of both agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Magnesium Salts may decrease the absorption of Tetracycline Derivatives. Only applicable to oral preparations of each agent.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Magnesium Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F3345287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to Aspirin monograph.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3345276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to Aspirin monograph for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F3345278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Salicylates are excreted into human milk. Refer to Aspirin monograph for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Doans Extra Strength Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     580 mg (24): $5.23",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Doans Pills Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     325 mg (24): $4.36",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Momentum Muscular Backache Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     580 mg (24): $5.81",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (MST 600 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600 mg (100): $55.93",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F191023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Therapeutic range of salicylate for arthritis treatment: 20-30 mg/dL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F191028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bexidermil (ES);",
"     </li>",
"     <li>",
"      Dencorub (AU);",
"     </li>",
"     <li>",
"      Geniol Flex (AR);",
"     </li>",
"     <li>",
"      Metsal AR (AU);",
"     </li>",
"     <li>",
"      Salimag (PL);",
"     </li>",
"     <li>",
"      Topicrem (ES)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F3345288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid from stomach and upper intestine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Readily into most body fluids and tissues",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 50% to 90%; primarily albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Released into the plasma as salicylic acid which is enzymatically converted to salicyluric acid and salicylphenolic glucuronide",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 2 hours; increased with repeated dosing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Department of Health and Human Services, Food and Drug Administration, &ldquo;Labeling for Oral and Rectal Over-the-Counter Drug Products Containing Aspirin and Nonaspirin Salicylates; Reye's Syndrome Warning; Final Rule (29 CFR Part 201),&rdquo;",
"      <i>",
"       Fed Regist",
"      </i>",
"      , April 17, 2003, 18861-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/37/14932/abstract-text/10177739/pubmed\" id=\"10177739\" target=\"_blank\">",
"        10177739",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10124 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-89.32.226.102-7D0333FE40-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14932=[""].join("\n");
var outline_f14_37_14932=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709025\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191030\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191043\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191033\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191040\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191022\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191015\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191025\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191024\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3345281\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3345279\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191018\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299639\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3345286\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3345287\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3345276\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3345278\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323357\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191023\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191028\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3345288\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10124\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10124|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?17/16/17668?source=related_link\">",
"      Magnesium salicylate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_37_14933="Doxapram: Drug information";
var content_f14_37_14933=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Doxapram: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/34/38436?source=see_link\">",
"    see \"Doxapram: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F162830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dopram&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F162856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Respiratory Stimulant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F162832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Although manufacturer&rsquo;s dosing recommendations are presented for these FDA-approved indications, use of doxapram has largely been replaced by alternate preferred agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Respiratory depression following anesthesia:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Intermittent injection:",
"     </i>",
"     Initial: 0.5-1 mg/kg; may repeat at 5-minute intervals (only in patients who demonstrate initial response); maximum total dose: 2 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V. infusion:",
"     </i>",
"     Initial: 5 mg/minute until adequate response or adverse effects seen; decrease to 1-3 mg/minute; maximum total dose: 4 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Drug-induced CNS depression:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Intermittent injection:",
"     </i>",
"     Initial: Priming dose of 1-2 mg/kg; repeat after 5 minutes; may repeat at 1-2 hour intervals (until sustained consciousness); maximum: 3000 mg daily.  May repeat in 24 hours if necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V. infusion:",
"     </i>",
"     Initial: Priming dose of 1-2 mg/kg repeated in 5 minutes. If no response, wait 1-2 hours and repeat priming dose. If some stimulation is noted, initiate infusion at 1-3 mg/minute (depending on size of patient/depth of CNS depression); suspend infusion if patient begins to awaken. Infusion should not be continued for &gt;2 hours. May reinstitute infusion as described above, including bolus, after rest interval of 30 minutes to 2 hours; maximum: 3000 mg daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute hypercapnia secondary to COPD:",
"     </b>",
"     I.V. infusion: Initial: Initiate infusion at 1-2 mg/minute (depending on size of patient/depth of CNS depression); may increase to maximum rate of 3 mg/minute; infusion should not be continued for &gt;2 hours. Monitor arterial blood gases prior to initiation of infusion and at 30-minute intervals during the infusion (to identify possible development of acidosis/CO",
"     <sub>",
"      2",
"     </sub>",
"     retention). Additional infusions are not recommended (per manufacturer).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F15508759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/34/38436?source=see_link\">",
"      see \"Doxapram: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;12 years and Adolescents: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F162833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15508760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling (has not been studied); however, use caution in severe impairment due to the potential for altered pharmacokinetics.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15508761\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling (has not been studied); however, use caution in severe impairment due to the potential for altered pharmacokinetics.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F162814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 20 mg/mL (20 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dopram&reg;: 20 mg/mL (20 mL) [contains benzyl alcohol]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F162799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F162816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer I.V. as an intermittent bolus or as an I.V. infusion. Avoid rapid infusion. Avoid extravasation.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F162862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Caffeine citrate, erythromycin lactobionate, gentamicin, metoclopramide, ranitidine, vancomycin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Clindamycin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ampicillin, calcium chloride, calcium gluconate, cefazolin, ceftazidime, fentanyl, heparin, insulin (regular), metronidazole, oxacillin, phenobarbital.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F162815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Respiratory stimulant for respiratory depression secondary to anesthesia, mild-to-moderate drug-induced respiratory and CNS depression; acute hypercapnia secondary to COPD",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     In general, the use of doxapram as a respiratory stimulant in adults is limited; alternate therapies are preferred.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F162864\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Doxapram may be confused with doxazosin, doxepin, DOXOrubicin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Dopram&reg; may be confused with DOPamine",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Doxapram may be confused with Doxinate brand name for doxylamine and pyridoxine [Italy]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F162854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, blood pressure increased, chest pain, chest tightness, flushing, heart rate changes, T waves lowered, ventricular tachycardia, ventricular fibrillation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Apprehension, Babinski turns positive, disorientation, dizziness, hallucinations, headache, hyperactivity, pyrexia, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Burning sensation, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Defecation urge, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Spontaneous voiding, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Hematocrit decreased, hemoglobin decreased, hemolysis, red blood cell count decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Phlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Clonus, deep tendon reflexes increase, fasciculations, involuntary muscle movement, muscle spasm, paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Pupillary dilatation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Albuminuria, BUN increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, cough, dyspnea, hiccups, hyperventilation, laryngospasm, rebound hypoventilation, tachypnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Emergence agitation, second-degree AV block (premature neonates), QT-interval prolonged (premature neonates)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F162819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to doxapram or any component of the formulation; significant cardiovascular impairment (eg, uncompensated heart failure, severe coronary artery disease); severe hypertension (including severe hypertension associated with hyperthyroidism or pheochromocytoma); cerebral edema, cerebral vascular accident, epilepsy, head injury; mechanical disorders of ventilation (eg, mechanical obstruction, muscle paresis, neuromuscular blockade, flail chest, pneumothorax, acute asthma, pulmonary fibrosis); pulmonary embolism",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F162803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular effects: May cause dysrhythmias; monitor for disturbances of cardiac rhythm. If sudden hypotension develops during use, discontinue. Increases in blood pressure are generally modest; use is contraindicated in patients with severe hypertension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS stimulation: May cause severe CNS stimulation, including seizures; anticonvulsants (as well as oxygen and resuscitative equipment) should be available to manage potential excessive CNS stimulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cerebrovascular disease: Use with caution in patients with cerebrovascular disease; lowered pCO",
"     <sub>",
"      2",
"     </sub>",
"     induced by hyperventilation produces cerebral vasoconstriction and decreased circulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Do",
"     <b>",
"      not",
"     </b>",
"     use in patients on mechanical ventilation. Use with caution in treating pulmonary disease; a pressor effect on pulmonary circulation may result in a fall in arterial pO",
"     <sub>",
"      2",
"     </sub>",
"     . If sudden dyspnea develops during use, discontinue. Doxapram causes patients to increase the work of breathing; therefore, do not increase the rate of infusion in an attempt to lower the pCO",
"     <sub>",
"      2",
"     </sub>",
"     in severely-ill COPD patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; MAO inhibitors (MAOIs): Use caution with coadministration; additive pressor effect may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sympathomimetics: Use caution with coadministration; additive pressor effect may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Volatile anesthetics: If patient has received anesthesia with a volatile agent known to sensitize the myocardium to catecholamines, avoid use of doxapram until anesthetic has been eliminated to decrease the risk of ventricular tachycardia or ventricular fibrillation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Benzyl alcohol: Solution contains benzyl alcohol which has been associated with \"gasping syndrome\" in neonates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Administration: Avoid extravasation; doxapram may cause thrombophlebitis or local skin irritation. Hemolysis may result from rapid infusion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Adequate airway required prior to use; consider airway protection in case of vomiting. Resuscitative equipment (in addition to anticonvulsants and oxygen) should be readily available; doxapram alone may not be sufficient to stimulate spontaneous breathing or provide sufficient arousal. Doxapram is neither an antagonist to skeletal muscle relaxants nor an opioid antagonist. Use with caution in patients with hypermetabolic states (eg, hyperthyroidism, pheochromocytoma).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F162808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypertensive effect of Doxapram.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F162810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F162821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse fetal effects have not been observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F162835\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Doxapram HCl Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg/mL (20 mL): $66.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F162812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor heart rate, blood pressure, deep tendon reflexes, CNS status, ECG, arterial blood gases (COPD)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Boda (CL);",
"     </li>",
"     <li>",
"      Caropraml (IN);",
"     </li>",
"     <li>",
"      Docatone (ES);",
"     </li>",
"     <li>",
"      Dopram (AT, AU, BE, CH, DE, DK, FI, FR, GB, GR, IE, NL, NO, ZA);",
"     </li>",
"     <li>",
"      Mopram (KP);",
"     </li>",
"     <li>",
"      Tapram (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F162802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stimulates respiration through action on peripheral carotid chemoreceptors; respiratory center in medulla is also directly stimulated as dosage is increased",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F162818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Respiratory stimulation: Single I.V. injection: 20-40 seconds",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peak effect: Single I.V. injection: 1-2 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Single I.V. injection: 5-12 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination, serum: Adults: Mean: 3.4 hours (range: 2.4-4.1 hours)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      De Villiers GS, Walele A, Van der Merwe PL, et al, &ldquo;Second-Degree Atrioventricular Heart Block After Doxapram Administration,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1998, 133(1):149-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/37/14933/abstract-text/9672531/pubmed\" id=\"9672531\" target=\"_blank\">",
"        9672531",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Maillard C, Boutroy MJ, Fresson J, et al, &ldquo;QT Interval Lengthening in Premature Infants Treated With Doxapram,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 2001, 70(6):540-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/37/14933/abstract-text/11753270/pubmed\" id=\"11753270\" target=\"_blank\">",
"        11753270",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robson RH and Prescott LF, &ldquo;A Pharmacokinetic Study of Doxapram in Patients and Volunteers,&rdquo;",
"      <i>",
"       Br J Clin Pharmacol",
"      </i>",
"      , 1979, 7(1):81-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/37/14933/abstract-text/32901/pubmed\" id=\"32901\" target=\"_blank\">",
"        32901",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yu D, Chai W, Sun X, et al, &ldquo;Emergence Agitation in Adults: Risk Factors in 2,000 Patients,&rdquo;",
"      <i>",
"       Can J Anaesth",
"      </i>",
"      , 2010, 57(9):843-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/37/14933/abstract-text/20526708/pubmed\" id=\"20526708\" target=\"_blank\">",
"        20526708",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9388 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-AF04787F30-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14933=[""].join("\n");
var outline_f14_37_14933=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162830\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162856\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162832\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15508759\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162833\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15508760\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15508761\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162814\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162799\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162816\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162862\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162815\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162864\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162854\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162819\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162803\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299230\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162808\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162810\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162821\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162835\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323120\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162812\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038604\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162802\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162818\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9388\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9388|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/34/38436?source=related_link\">",
"      Doxapram: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_37_14934="Dementia (including Alzheimer disease)";
var content_f14_37_14934=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?14/37/14934/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14934/contributors\" id=\"au4635\">",
"       Michael Alexander, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14934/contributors\" id=\"au1149\">",
"       Eric B Larson, MD, MPH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?14/37/14934/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14934/contributors\" id=\"se1617\">",
"       Steven T DeKosky, MD, FAAN",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?14/37/14934/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14934/contributors\" id=\"de8764\">",
"       April F Eichler, MD, MPH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?14/37/14934?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      DEMENTIA OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Dementia is a general term used to indicate that a person has developed difficulties with reasoning, judgment, and memory. People who have dementia usually have some memory loss and difficulty with at least one other area, such as:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Speaking or writing coherently (or understanding what is said or written)",
"      </li>",
"      <li>",
"       Recognizing familiar surroundings",
"      </li>",
"      <li>",
"       Planning and carrying out multi-step tasks",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In order to be considered dementia these changes must be severe enough to interfere with a person's independence and daily activities.",
"    </p>",
"    <p>",
"     Dementia can be caused by several diseases that affect the brain. The most common cause is Alzheimer disease. Alzheimer disease accounts for 60 to 80 percent of all cases of dementia.",
"    </p>",
"    <p>",
"     This article will discuss the main causes of dementia, focusing primarily on Alzheimer disease. It will also review the most common treatments and self-care strategies that can help with dementia. More detailed information about dementia and Alzheimer disease are available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=see_link\">",
"      \"Evaluation of cognitive impairment and dementia\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33865?source=see_link\">",
"      \"Treatment of dementia\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      CAUSES OF DEMENTIA",
"     </span>",
"    </p>",
"    <p>",
"     Dementia can be caused by several different brain disorders. These include:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Alzheimer disease",
"     </span>",
"     &nbsp;&mdash;&nbsp;Alzheimer disease is associated with the death of nerve cells (neurons) in important parts of the brain. Scientists have not yet determined exactly why and how Alzheimer disease develops, but they do know that the brains of patients with Alzheimer disease develop deposits of a protein called beta amyloid (these deposits are also known as plaques), and that people also develop disorganized masses of protein fibers within the brain cells known as neurofibrillary tangles.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Vascular dementia",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with vascular dementia have lost or damaged areas of brain because of reduced blood flow. This can happen when the blood vessels in the brain get clogged with blood clots or fatty deposits. This form of dementia is more common among people who have had strokes or are at risk for strokes, especially those with longstanding high blood pressure and diabetes. It can occur together with Alzheimer disease. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/57/37786?source=see_link\">",
"      \"Etiology, clinical manifestations, and diagnosis of vascular dementia\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Dementia with Lewy bodies",
"     </span>",
"     &nbsp;&mdash;&nbsp;Dementia with Lewy bodies is a form of dementia caused by abnormal protein structures called Lewy bodies forming within brain cells. It occurs with symptoms of Parkinson disease, such as trembling, stiffness, and slowness. This disorder often causes vivid and long-lasting hallucinations. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link\">",
"      \"Clinical features and diagnosis of dementia with Lewy bodies\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=see_link\">",
"      \"Prognosis and treatment of dementia with Lewy bodies\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Parkinson disease dementia",
"     </span>",
"     &nbsp;&mdash;&nbsp;Dementia can also occur later in the course of Parkinson disease and has symptoms that are very similar to dementia with Lewy bodies. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/4/5188?source=see_link\">",
"      \"Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"      \"Parkinson disease dementia\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Frontotemporal dementia (formerly called Pick's disease)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Like Alzheimer disease, frontotemporal dementia causes nerve cell loss in the brain, but frontotemporal dementia targets two specific parts of the brain, called the frontal and temporal lobes.",
"    </p>",
"    <p>",
"     Frontotemporal dementia usually arises at an earlier age than Alzheimer disease. Three forms are more common than others: One causes personality changes and abnormal social behavior; one impairs speech and eventually leaves the patient unable to speak; another causes difficulty in understanding language. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12618?source=see_link\">",
"      \"Frontotemporal dementia: Clinical features and diagnosis\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Other causes of dementia",
"     </span>",
"     &nbsp;&mdash;&nbsp;Dementia can also be caused by cumulative damage to the brain, which can occur in people with chronic alcoholism or repeated head injuries (eg, among former professional boxers or football players).",
"    </p>",
"    <p>",
"     Many persons at more advanced old age (85 and greater) have more than one cause of dementia, for example, Alzheimer disease and vascular dementia.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      DEMENTIA RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     Each form of dementia has its own risk factors, but most forms have several risk factors in common.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Age",
"     </span>",
"     &nbsp;&mdash;&nbsp;The biggest risk factor for dementia is age: dementia is uncommon in people younger than 60 years old.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Family history",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some forms of dementia have a heritable component, meaning that they tend to run in families. Having a close family member with Alzheimer disease increases your chances of developing it. People with a first-degree relative, such as a parent or sibling, with Alzheimer disease have a 10 to 30 percent chance of developing the disorder. The risk is probably highest if the family member developed Alzheimer disease at a younger age (less than 70 years old) and is lower if the family member did not get Alzheimer disease until late in life.",
"    </p>",
"    <p>",
"     Scientists have discovered a particular gene, called APOE epsilon 4, that increases a person's risk of developing Alzheimer disease. But even among individuals with this gene, only about one-half develop Alzheimer disease by age 90, suggesting that other factors are also involved. The test is not currently recommended unless you are involved in a research study (",
"     <a class=\"external\" href=\"file://www.alzheimers.org/clinicaltrials/search.asp\">",
"      www.alzheimers.org/clinicaltrials/search.asp",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Other factors",
"     </span>",
"     &nbsp;&mdash;&nbsp;Studies indicate that high blood pressure, smoking, and diabetes may be risk factors for dementia, although experts are still not sure how treatment for these problems influence your risk of developing dementia.",
"    </p>",
"    <p>",
"     Lifestyle factors have also been implicated in dementia. For instance, it seems as though people who remain physically active, socially connected, and mentally engaged seem less likely to fall prey to dementia (or develop dementia later) than people who do not do these things.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      DEMENTIA SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Each form of dementia can cause difficulty with memory, language, reasoning, and judgment, but the symptoms are often slightly different. These differences are usually noticeable only to skilled healthcare providers who have experience working with people with dementia.",
"    </p>",
"    <p>",
"     Since Alzheimer disease is the most common cause of dementia, and the symptoms of other forms of dementia often overlap, the sections below will focus on the symptoms of Alzheimer disease.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Is memory loss normal?",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many people worry that memory problems are caused by early Alzheimer disease. Normal age-related changes usually cause minor difficulties in short term memory and a slowed ability to learn and process information. These changes are usually mild and do not worsen greatly over time in normal aging, nor should they interfere with a person's day-to-day functioning.",
"    </p>",
"    <p>",
"     Sometimes people with memory difficulty are labeled as having mild cognitive impairment (MCI). Some people with MCI, although not all, develop dementia over time. While people with MCI can often function normally, they are monitored closely for signs of dementia and Alzheimer disease. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/33/27161?source=see_link\">",
"      \"Mild cognitive impairment: Epidemiology, pathology, and clinical assessment\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Early changes",
"     </span>",
"     &nbsp;&mdash;&nbsp;The earliest symptoms of Alzheimer disease are gradual and often subtle. Many people and their families first notice difficulty remembering recent events or information. Other changes can include one or more of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Confusion",
"      </li>",
"      <li>",
"       Difficulties with language (eg, not being able to find the right words for things)",
"      </li>",
"      <li>",
"       Difficulty with concentration and reasoning",
"      </li>",
"      <li>",
"       Problems with complex tasks like paying bills or balancing a checkbook",
"      </li>",
"      <li>",
"       Getting lost in a familiar place",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Late changes",
"     </span>",
"     &nbsp;&mdash;&nbsp;As Alzheimer disease progresses, a person's ability to think clearly continues to decline, and personality and behavioral symptoms are more likely to be troublesome. These can include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Increased anger or hostility, sometimes aggressive behavior; alternatively some people become very passive",
"      </li>",
"      <li>",
"       Hallucinations",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       delusions",
"      </li>",
"      <li>",
"       Disorientation",
"      </li>",
"      <li>",
"       Needing help with basic tasks (eating, bathing, dressing)",
"      </li>",
"      <li>",
"       Incontinence (leaking urine or feces)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The number of symptoms and speed with which symptoms progress can vary widely from one person to the next. In some people, severe dementia occurs within five years of the diagnosis; for others, the process can take more than 10 years. Most people with Alzheimer disease do not die from the disease itself, but instead die from a secondary illness such as pneumonia, bladder infection, or complications of a fall.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      DEMENTIA DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Brain scans and other laboratory tests are not usually useful in diagnosing dementia or in identifying the type of dementia. For this, healthcare providers typically rely on the information they can gather by interacting with the person and speaking with his or her family members. The provider will typically perform memory and other cognitive (thinking) tests to assess the person's degree of difficulty with different types of problems. The results of these tests can be monitored over time.",
"    </p>",
"    <p>",
"     Brain scans (either CT or MRI) are usually performed in people with dementia to rule out other problems. Blood tests may also be performed to see if a chemical or hormonal imbalance or vitamin deficiency is contributing to the person's difficulties.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      SAFETY AND LIFESTYLE ISSUES FOR PEOPLE WITH DEMENTIA",
"     </span>",
"    </p>",
"    <p>",
"     A major issue for caregivers of people with dementia is being sure the person stays safe. Because many people with dementia do not realize that their mental functioning is impaired, they try to continue their day-to-day activities as usual. This can lead to physical danger, and caregivers must help to avoid situations that can threaten the safety of the patient or others.",
"    </p>",
"    <p>",
"     The following information applies specifically to people with Alzheimer disease, but much of it is also relevant to people with other forms of dementia. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4552?source=see_link\">",
"      \"Safety and societal issues related to dementia\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Driving",
"     </span>",
"     &nbsp;&mdash;&nbsp;Driving is often one of the first safety issues that arises in people with Alzheimer disease. In people with Alzheimer disease, the risk of having a car accident is significantly increased, especially as the disease progresses. It is best to discuss the issue of driving early. Over time, everyone with dementia will reach a point where driving is too dangerous.",
"    </p>",
"    <p>",
"     Losing the ability to drive is hard to face because it represents independence for many people. The person may resist limits on driving because he or she does not completely appreciate",
"     <span class=\"nowrap\">",
"      his/her",
"     </span>",
"     impairments in mental functioning or reaction time.",
"    </p>",
"    <p>",
"     A roadside driving test is often recommended if there is disagreement or uncertainty about a person's ability to drive. However, if a person with newly diagnosed, mild Alzheimer disease is deemed still able to drive, their ability to drive needs to be reassessed every six months, with the expectation that driving will eventually no longer be possible.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Cooking",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cooking is another area that can lead to serious safety concerns and may require supervision. Symptoms such as distractibility, forgetfulness, and difficulty in following directions can lead to burns, fires, or other injuries.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Wandering",
"     </span>",
"     &nbsp;&mdash;&nbsp;As dementia progresses, some people with Alzheimer disease begin to wander. Because restlessness, distractibility, and memory problems are common, a person who wanders may easily become lost. Identification bracelets can help ensure that a lost wanderer gets home. The Alzheimer's Association provides a \"safe return\" program with ID tags and 24-hour assistance (",
"     <a class=\"external\" href=\"file://www.alz.org/we_can_help_safe_return.asp\">",
"      www.alz.org/we_can_help_safe_return.asp",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Regular exercise may decrease the restlessness that can lead to wandering. For those who continue to wander, alarm systems are available that alert caretakers when the wearer leaves the home.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Falls",
"     </span>",
"     &nbsp;&mdash;&nbsp;For all types of dementia, including Alzheimer disease, falls are a safety concern. To reduce the risk of falls, eliminate potential hazards such as loose electrical cords, slippery rugs, and so forth. Regular exercise, especially early in the course of dementia, can help reduce the risk of falls.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h1\">",
"      DEMENTIA TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The treatment for dementia depends in part on the type of dementia. People with vascular dementia should focus on getting their blood pressure and cholesterol under control to reduce the risk of further damage to the brain. People with dementia with parkinsonism, meanwhile, sometimes need medications used to manage Parkinson disease (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/63/30708?source=see_link\">",
"      \"Patient information: Parkinson disease treatment options &mdash; medications (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Although scientists are learning more about Alzheimer disease all the time, there is currently no cure. There are a number of medications that may help to control some of the symptoms of Alzheimer disease. The section below addresses treatment for Alzheimer disease, but these treatments are also being used in people with other forms of dementia.",
"    </p>",
"    <p>",
"     These include medications to manage memory as well as behavioral problems. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33865?source=see_link\">",
"      \"Treatment of dementia\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Treatment of memory problems",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are several medicines currently available for treating Alzheimer disease. Three of these medications are cholinesterase inhibitors:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Donepezil (Aricept&reg;)",
"      </li>",
"      <li>",
"       Rivastigmine (Exelon&reg;)",
"      </li>",
"      <li>",
"       Galantamine (Razadyne&reg;)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     These medications allow more of a chemical called acetylcholine to be active in the brain, thus making up for Alzheimer disease-related drops in acetylcholine levels. Cholinesterase inhibitors can cause side effects of nausea, vomiting, and diarrhea in some people. In some patients, these medicines can cause fainting spells, which should be discussed with a doctor or nurse. When taken at bedtime, these medicines can cause very vivid dreams.",
"    </p>",
"    <p>",
"     Memantine (Namenda&reg;) is a unique medicine that works differently than cholinesterase inhibitors. It may protect the brain from further damage caused by Alzheimer disease. Dizziness is the most common side effect, and aggression and hallucinations may worsen in some people. It is usually used along with a cholinesterase inhibitor.",
"    </p>",
"    <p>",
"     Today many persons will be offered one of these medicines as an option. A trial is usually begun for a period of about eight weeks while the person is monitored for side effects and response. If there is no improvement or side effects are bothersome, the medicine is usually stopped. Sometimes the person will worsen after the medicine is stopped; if this happens, the medicine may be started again. The medicines should periodically be evaluated to see if they are providing any benefit.",
"    </p>",
"    <p>",
"     It is important to have realistic expectations about the potential benefits of these medicines. None of these medicines cures Alzheimer disease, most people are disappointed with the results, and over time the patient will continue to worsen. When these medicines are effective, the hope is that the patient and their family will have an improved quality of life for a longer period.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Treatment of behavioral symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;The behavioral symptoms of Alzheimer disease are often more troubling than the cognitive symptoms. Even in mild cases, agitation, anxiety, and irritability can occur, and generally worsen as Alzheimer disease advances. A combination of medicines and behavioral therapy may be helpful. Nonpharmacologic behavioral modification therapies are preferred as virtually all medications used for behavioral symptoms can increase confusion. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link\">",
"      \"Treatment of behavioral symptoms related to dementia\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h3\">",
"      Depression",
"     </span>",
"     &nbsp;&mdash;&nbsp;Depression is common, especially in the early phases of dementia. It may be managed with behavioral therapy",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     with medications. The key is to recognize the presence of dementia. If depression is causing distress it is worth treating. Potentially helpful medicines include a group of medicines known as selective serotonin reuptake inhibitors, or SSRIs, which are usually preferred over other choices in patients with dementia. Widely used SSRIs include fluoxetine (Prozac&reg;), sertraline (Zoloft&reg;), paroxetine (Paxil&reg;), citalopram (Celexa&reg;), and escitalopram (Lexapro&reg;).",
"    </p>",
"    <p>",
"     A variety of behavioral therapies are often helpful, do not have the side effects often seen with medications, and may be recommended for depression. Behavioral therapy involves changing the environment (eg, encouraging exercise, avoiding triggers that cause sadness, socializing with others, engaging in pleasant activities that a person enjoys).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h3\">",
"      Anxiety and aggression",
"     </span>",
"     &nbsp;&mdash;&nbsp;One of the most difficult issues for caregivers and people with Alzheimer disease is aggressive behavior. Fortunately, this behavior is not common. However, many family members are reluctant to report aggressive behavior. In some cases, the behavior becomes physically abusive as dementia progresses. In addition, some caregivers become so frustrated that they themselves begin to behave abusively.",
"    </p>",
"    <p>",
"     Anxiety and aggression can be caused by a number of factors, including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Confusion or misunderstanding, disorientation",
"      </li>",
"      <li>",
"       Frightening or paranoid delusions or hallucinations",
"      </li>",
"      <li>",
"       Depression",
"      </li>",
"      <li>",
"       Sleep disorders, reduced sleep or altered",
"       <span class=\"nowrap\">",
"        sleep/wake",
"       </span>",
"       cycles",
"      </li>",
"      <li>",
"       Medical conditions such as difficulty urinating or severe constipation, other causes of physical pain or discomfort",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Delusions are common in patients with dementia, occurring in up to 30 percent of those with advanced disease. Paranoid delusions are particularly distressing to both the patients and the caregivers: these often include beliefs that someone has invaded the house, that family members have been replaced by impostors, that spouses have been unfaithful, or that personal possessions have been stolen.",
"    </p>",
"    <p>",
"     Family members should discuss any concerns regarding aggressive behavior with a healthcare provider, and arrange for help if necessary. The best treatment for these symptoms depends upon what triggers them. As an example, a person who becomes aggressive during periods of confusion might best be treated by talking through the problem, while someone who becomes aggressive during delusions might require medicine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H28\">",
"     <span class=\"h3\">",
"      Sleep problems",
"     </span>",
"     &nbsp;&mdash;&nbsp;Sleep disorders can be treated with either medicine or behavior changes or both: for example, limiting daytime naps, increasing physical activity, avoiding caffeine and alcohol in the evening. In some people, a sleeping medicine may be recommended, although these medicines almost always will have side effects (worsened confusion).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h1\">",
"      LIFE WITH DEMENTIA",
"     </span>",
"    </p>",
"    <p>",
"     Being diagnosed with any form of dementia can be overwhelming both for patients and for their loved ones.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30\">",
"     <span class=\"h2\">",
"      For people with dementia",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is important for people with early dementia to care for their physical and mental health. This means getting regular checkups, taking medicines if needed, eating a healthy diet, exercising regularly, getting enough sleep, and avoiding activities that may be risky.",
"    </p>",
"    <p>",
"     It is often helpful to talk to others through support groups or a counselor or social worker to discuss feelings of anxiety, frustration, anger, loneliness, or depression. All of these feelings are normal, and dealing with these feelings can help you to feel more in control of your wellbeing.",
"    </p>",
"    <p>",
"     Another issue to consider is how to tell family and friends about the diagnosis of dementia. Explaining the disease can help others to understand what to expect and how they can help, now and in the future. This can be especially helpful for children and grandchildren, who may not be familiar with the condition.",
"    </p>",
"    <p>",
"     You may live alone in the early stages in the early stages of dementia, but you may need help with tasks such as housekeeping, cooking, transportation, and paying bills. If possible, ask a friend or family member for help to develop plans to deal with these and other issues as dementia progresses. Occupational therapists, and sometimes speech pathologists, can help to set up your home to minimize confusion and keep you independent for as long as possible.",
"    </p>",
"    <p>",
"     In addition, you should discuss your preferences regarding issues that are likely to become important as dementia worsens, including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Is health insurance available?",
"      </li>",
"      <li>",
"       Where will I live?",
"      </li>",
"      <li>",
"       Who will make healthcare and end of life decisions?",
"      </li>",
"      <li>",
"       Who will pay for care?",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     A number of resources are available to assist in this type of planning. (See",
"     <a class=\"local\" href=\"#H32\">",
"      'Where to get more information'",
"     </a>",
"     below.) In some communities there are support groups specifically for people with frontotemporal dementia. These may be a better fit than groups for anyone with dementia since people with FTD are often younger and may have more bothersome behavioral problems.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H31\">",
"     <span class=\"h2\">",
"      For caregivers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Dementia is debilitating and can impose an enormous burden on patients and families or other caregivers. People with dementia become less able to care for themselves as the condition progresses. Some tips that may help caregivers include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Make a daily plan and prepare to be flexible if needed.",
"      </li>",
"      <li>",
"       Try to be patient when responding to repetitive questions, behaviors, or statements. This type of behavior is common, and often related to feeling insecure or nervous.",
"      </li>",
"      <li>",
"       Use memory aids such as writing out a list of daily activities, phone numbers, and instructions for usual tasks (ie, the telephone, microwave, etc).",
"      </li>",
"      <li>",
"       Establish calm nighttime routines to manage behavioral problems, which are often worst at night. Leave a night light on in the person's bedroom.",
"      </li>",
"      <li>",
"       Avoid major changes to the home environment.",
"      </li>",
"      <li>",
"       Employ safety measures in the home, such as locks on medicine cabinets, keep furniture in the same place to prevent falls, remove electrical appliances from the bathroom, install grab bars in the bathroom, and set the water heater below 120&ordm;F.",
"      </li>",
"      <li>",
"       Help the patient perform personal care as they are willing and able. It is not necessary to bathe every day, although a healthcare provider should be notified if the person develops sores in the mouth or genitals related to hygiene problems (eg, urinary leakage, ill-fitting dentures).",
"      </li>",
"      <li>",
"       Speak slowly, present only one idea at a time, and be patient when waiting for responses.",
"      </li>",
"      <li>",
"       Encourage physical activity and exercise. A daily walk can help prevent physical decline and improve behavioral problems.",
"      </li>",
"      <li>",
"       Consider respite care. Respite care can provide a needed break for family and can strengthen the family's ability to provide care in the future. This is offered in many communities in the form of in-home care or adult day care. Caregiving can be an all-consuming experience. Be sure to take time for yourself, take care of your own medical problems, and arrange for breaks when you need them.",
"      </li>",
"      <li>",
"       Try not to argue or confront persons with dementia when they express mistaken ideas or facts. Change the subject or gently remind them of an inaccuracy. Arguing or trying to convince a person of &ldquo;the truth&rdquo; can be frustrating to all and can trigger unwanted behavior and feelings.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H32\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H321\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6662890\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/14/31970?source=see_link\">",
"      Patient information: Dementia (including Alzheimer disease) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/3/18482?source=see_link\">",
"      Patient information: Dementia with Lewy bodies (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/12/35009?source=see_link\">",
"      Patient information: Dementia with HIV (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/3/7218?source=see_link\">",
"      Patient information: Elder abuse (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/22/32098?source=see_link\">",
"      Patient information: Tips for caregivers of people with Alzheimer disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/20/2370?source=see_link\">",
"      Patient information: Mild cognitive impairment (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/3/31793?source=see_link\">",
"      Patient information: Evaluating memory and thinking problems (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/15/6387?source=see_link\">",
"      Patient information: Vitamin B12 deficiency and folate (folic acid) deficiency (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/50/25378?source=see_link\">",
"      Patient information: Creutzfeldt-Jakob disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/24/1411?source=see_link\">",
"      Patient information: Time to stop driving? (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6662991\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/4/5188?source=see_link\">",
"      Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/63/30708?source=see_link\">",
"      Patient information: Parkinson disease treatment options &mdash; medications (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H34\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1913?source=see_link\">",
"      Cholinesterase inhibitors in the treatment of dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link\">",
"      Clinical features and diagnosis of dementia with Lewy bodies",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/28/31176?source=see_link\">",
"      Diseases of the central nervous system caused by prions",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/41/34455?source=see_link\">",
"      Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/57/37786?source=see_link\">",
"      Etiology, clinical manifestations, and diagnosis of vascular dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=see_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12618?source=see_link\">",
"      Frontotemporal dementia: Clinical features and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/33/27161?source=see_link\">",
"      Mild cognitive impairment: Epidemiology, pathology, and clinical assessment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26138?source=see_link\">",
"      Mild cognitive impairment: Prognosis and treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"      Parkinson disease dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41369?source=see_link\">",
"      Prevention of dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=see_link\">",
"      Prognosis and treatment of dementia with Lewy bodies",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36202?source=see_link\">",
"      Risk factors for dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4552?source=see_link\">",
"      Safety and societal issues related to dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10104?source=see_link\">",
"      Treatment and prevention of vascular dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link\">",
"      Treatment of behavioral symptoms related to dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33865?source=see_link\">",
"      Treatment of dementia",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Neurological Disorders and Stroke",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ninds.nih.gov/\">",
"      www.ninds.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Administration on Aging (Department of Health and Human Services)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.aoa.gov/\">",
"      www.aoa.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The American Geriatrics Society",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.americangeriatrics.org/\">",
"      www.americangeriatrics.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Alzheimer's Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.alz.org/\">",
"      www.alz.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Associate of Frontotemporal Dementias",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ftd-picks.org/\">",
"      www.ftd-picks.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Alzheimer's Disease Education and Referral (ADEAR) Center (National Institute on Aging)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nia.nih.gov/alzheimers\">",
"      www.nia.nih.gov/alzheimers",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Eldercare Locator (Administration on Aging)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.eldercare.gov/\">",
"      www.eldercare.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Family Caregiver Alliance",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.caregiver.org/\">",
"      www.caregiver.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?14/37/14934/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 1, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?14/37/14934?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14934/abstract/1\">",
"      Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995; 273:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14934/abstract/2\">",
"      Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol 1998; 148:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14934/abstract/3\">",
"      Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14934/abstract/4\">",
"      Qaseem A, Snow V, Cross JT Jr, et al. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2008; 148:370.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f14_37_14934=[""].join("\n");
var outline_f14_37_14934=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           DEMENTIA OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           CAUSES OF DEMENTIA",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           DEMENTIA RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           DEMENTIA SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           DEMENTIA DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           SAFETY AND LIFESTYLE ISSUES FOR PEOPLE WITH DEMENTIA",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H23\">",
"           DEMENTIA TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H29\">",
"           LIFE WITH DEMENTIA",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H32\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f14_37_14935="Staging and prognosis of Hodgkin lymphoma";
var content_f14_37_14935=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Staging and prognosis of Hodgkin lymphoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/37/14935/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14935/contributors\">",
"     Peter M Mauch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14935/contributors\">",
"     George P Canellos, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/37/14935/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14935/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/37/14935/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14935/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/37/14935/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once a diagnosis of Hodgkin lymphoma (formerly called Hodgkin's disease, HL) is made, the clinical stage of disease is determined to guide treatment and act as a measure of prognosis. The main goals of staging are to measure the extent of disease and associated prognostic factors, and to define disease manifestations that can be reevaluated during and after treatment to determine the effectiveness of therapy. Staging also serves an important role for the comparison of treatments among studies.",
"   </p>",
"   <p>",
"    The TNM (tumor node metastasis) staging system that is generally used for solid tumors is not applicable to lymphoma, since it is based upon the concept of a primary tumor and metastasis. Instead, the staging system used for HL is an anatomical classification, which is based upon the concept that HL spreads in a predictable pattern of contiguous disease. HL starts at a single site within the lymphatic system, usually a lymph node, and then progresses to adjacent lymph nodes via lymphatic channels before disseminating to distant nonadjacent sites and organs.",
"   </p>",
"   <p>",
"    Patients with Hodgkin lymphoma are staged according to the Ann Arbor staging system with Cotswolds modifications [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. This is a four-stage system (stages I to IV). The original Ann Arbor staging system was developed in 1974 and was principally based upon the use of staging laparotomy and lymphangiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/1\">",
"     1",
"    </a>",
"    ]. In 1988, the Cotswold modifications added valuable information regarding the presence of bulky disease and the efficacy of imaging studies for staging [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss the staging of patients with HL. Other topic reviews discuss the clinical presentation, diagnosis, treatment, and other prognostic measures of these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15578?source=see_link\">",
"     \"Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=see_link\">",
"     \"Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29206?source=see_link\">",
"     \"Initial evaluation and diagnosis of Hodgkin lymphoma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13512?source=see_link\">",
"     \"Overview of the treatment of classical Hodgkin lymphoma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANN ARBOR STAGING SYSTEM WITH COTSWOLDS MODIFICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Overview of staging notation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Ann Arbor staging system with Cotswolds modifications is the current staging system used for patients with Hodgkin lymphoma. Patients are staged either clinically or, much less often, pathologically. They are placed into one of four stages, based upon the sites of involvement, and are assigned numbers and letters that designate the number of lymph node regions involved and the presence or absence of systemic symptoms or of bulky or extended disease (",
"    <a class=\"graphic graphic_table graphicRef66651 \" href=\"UTD.htm?19/23/19836\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage I &mdash; Involvement of a single lymph node region (I) or of a single extralymphatic organ or site (IE).",
"     </li>",
"     <li>",
"      Stage II &mdash; Involvement of two or more lymph node regions on the same side of the diaphragm alone (II) or with involvement of limited, contiguous extralymphatic organ or tissue (IIE). The number of anatomic regions should be indicated by a subscript (eg, II-3).",
"     </li>",
"     <li>",
"      Stage III &mdash; Involvement of lymph node regions or lymphoid structures on both sides of the diaphragm (III) which may include the spleen (IIIS) or limited, a contiguous extralymphatic organ or site (IIIE) or both (IIIES). This may be subdivided into stage III-1 or III-2: stage III-1 is used for patients with involvement of the spleen or splenic hilar, celiac or portal nodes; and stage III-2 is used for patients with involvement of the paraaortic, iliac, inguinal, or mesenteric nodes.",
"     </li>",
"     <li>",
"      Stage IV &mdash; Diffuse or disseminated foci of involvement of one or more extralymphatic organs or tissues, with or without associated lymphatic involvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All cases are subclassified to indicate the absence (A) or presence (B) of one or more of the following three systemic symptoms: significant unexplained fever, night sweats, or unexplained weight loss exceeding 10 percent of body weight during the six months prior to diagnosis.",
"   </p>",
"   <p>",
"    The subscript \"X\" is used if bulky disease is present. No subscripts are used in the absence of bulk. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Criteria for bulky disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The subscript \"E\" is used if limited extranodal extension is documented. More extensive extranodal disease is designated stage IV. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Criteria for extranodal spread'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with stage I or stage II disease are then further stratified for treatment purposes into favorable and unfavorable prognosis disease based upon the presence or absence of certain clinical features, such as age, B symptoms, and large mediastinal adenopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10711?source=see_link&amp;anchor=H5#H5\">",
"     \"Definition of favorable and unfavorable prognosis early (stage I-II) classical Hodgkin lymphoma\", section on 'Favorable versus unfavorable disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Staging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The terms \"clinical stage\" and \"pathological stage\" are used to indicate the testing used to determine the anatomical stage of disease. While pathological staging was used frequently in the past, it has largely been abandoned because of the associated morbidity, improved imaging techniques, and a shift in practice away from the use of radiation therapy alone for the treatment of early stage disease [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical stage refers to the extent of disease determined by diagnostic tests following a single diagnostic biopsy. Clinical stage is determined by a history, physical examination, and imaging studies. The preferred imaging modalities are an upright chest radiograph and an integrated positron emission",
"      <span class=\"nowrap\">",
"       tomography/computed",
"      </span>",
"      tomography",
"      <span class=\"nowrap\">",
"       (PET/CT)",
"      </span>",
"      scan of the chest, abdomen, and pelvis. Most patients with HL have cervical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      supraclavicular nodal involvement, the extent of which can often be determined on the",
"      <span class=\"nowrap\">",
"       PET/CT.",
"      </span>",
"      However, if the",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      does not provide sufficient detail for radiation treatment planning, then a dedicated CT of the neck should be obtained. The upright chest radiograph should be obtained in addition to the CT because it is the preferred method for determining the presence or absence of bulky disease. A unilateral bone marrow aspirate and biopsy is performed for patients with stage III or IV disease and those with systemic B symptoms, although the yield is small, unless there is liver involvement. It can be omitted in other stages in patients receiving systemic therapy.",
"     </li>",
"     <li>",
"      Pathological stage is determined by staging laparotomy with splenectomy, liver biopsy, multiple lymph node biopsies, and bone marrow biopsy. Such staging is no longer used.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Determining organ involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomic criteria for clinical staging are defined as follows:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Lymph nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymph node involvement is defined as the clinical enlargement of a node when alternative pathology may reasonably be ruled out; the enlargement can be determined by physical examination, plain radiograph, or",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    scanning. Suspicious nodes should always be biopsied if treatment decisions are based on their involvement.",
"   </p>",
"   <p>",
"    For staging purposes, the lymph nodes are divided into anatomic regions that can be encompassed by a single radiation field, as follows (",
"    <a class=\"graphic graphic_figure graphicRef55422 \" href=\"UTD.htm?41/2/42021\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Waldeyer's ring (tonsils, base of the tongue, nasopharynx)",
"     </li>",
"     <li>",
"      Ipsilateral cervical, supraclavicular, occipital, and pre-auricular",
"     </li>",
"     <li>",
"      Infraclavicular",
"     </li>",
"     <li>",
"      Axillary and pectoral",
"     </li>",
"     <li>",
"      Mediastinal (thymus, prevascular, aortopulmonary; paratracheal, pretracheal, subcarinal, and posterior mediastinal)",
"     </li>",
"     <li>",
"      Hilar",
"     </li>",
"     <li>",
"      Paraaortic",
"     </li>",
"     <li>",
"      Spleen",
"     </li>",
"     <li>",
"      Iliac",
"     </li>",
"     <li>",
"      Ipsilateral inguinal and femoral",
"     </li>",
"     <li>",
"      Epitrochlear and brachial",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All nodal disease within the mediastinum is considered to be a single lymph node region. Hilar nodes are considered separate from the mediastinum and should be considered to be \"lateralized\" (right hilar and left hilar nodes are separate regions) such that, when involved on both sides, constitute stage II disease. Internal mammary nodes are part of the lymphatic system of the chest wall and drain the diaphragm. Paravertebral nodes, although in the posterior mediastinum, also drain the chest wall and diaphragm. For staging purposes, the internal mammary and paravertebral nodes in the chest can be considered mediastinal nodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Spleen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic involvement is noted when there are multiple focal defects, that are neither cystic nor vascular, noted on at least two imaging techniques. Two independent scans (ie, both PET and CT) are needed to determine disease involvement because of the high false positivity of the PET scan alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Liver",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver involvement is defined by the presence of multiple focal defects, which are neither cystic nor vascular, noted on at least two imaging techniques. Clinical hepatic enlargement alone with or without abnormalities of liver function tests is not adequate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Lung",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung involvement is defined by radiological evidence of parenchymal involvement on both PET and CT in the absence of other likely causes, particularly infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Bone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone involvement is suggested by a history of pain or elevation of serum alkaline phosphatase, and further supported by changes on plain radiograph or evidence from other imaging studies (isotope, CT, or magnetic resonance imaging [MRI])",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Central nervous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;A spinal intradural deposit or spinal cord or meningeal involvement can be diagnosed on the basis of the clinical history and findings supported by plain radiography, myelography, CT,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    MRI. Spinal extradural deposits should be carefully assessed since they may result from soft tissue disease that represents extension from bone metastasis or disseminated disease. Intracranial involvement is rarely diagnosed clinically at presentation. It should be considered on the basis of a space-occupying lesion in the presence of disease in other extranodal sites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Other sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical involvement of other extranodal sites may only be diagnosed if the site is contiguous or proximal to a known nodal site (ie, an E lesion). A biopsy can identify pathologic involvement of other extranodal sites not contiguous or proximal to known nodal sites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Criteria for B symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic B symptoms generally correlate with advanced stage and bulk disease and portend a worse prognosis. However, occasional patients with early or small-volume Hodgkin lymphoma have significant B symptoms, a finding that remains unexplained. There are three systemic B symptoms accepted as part of the staging system and are defined as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unexplained weight loss of more than 10 percent of body weight during the six months before initial staging investigation.",
"     </li>",
"     <li>",
"      Unexplained persistent or recurrent fever with temperatures above 38&ordm;C (&gt;100.4&ordm;F) during the previous month.",
"     </li>",
"     <li>",
"      Recurrent drenching night sweats during the previous month.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fever and weight loss appear to have more prognostic significance than drenching night sweats, which are considered by some to be the least important of the B symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. In one series, for example, patients with pathologically staged IA to IIA disease who had night sweats as their only B symptom had a similar prognosis to those without night sweats [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/7\">",
"     7",
"    </a>",
"    ]. In contrast, patients with fever and weight loss had reduced survival, whether treated by radiation therapy alone or combined modality therapy.",
"   </p>",
"   <p>",
"    Although other symptoms may be associated with Hodgkin lymphoma, they are not classified as B symptoms. However, some of these symptoms, such as severe pruritus and alcohol induced pain, may prove to be of prognostic significance and should be recorded [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Criteria for bulky disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bulky disease is denoted in the staging system by the subscript \"X\". Bulky disease has been variably defined by different investigational groups. In the Cotswolds modifications, bulky disease is defined by the presence of one of the following two findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An abdominal node or nodal mass that is 10 cm or greater in largest dimension as determined by CT, MRI, or ultrasound.",
"     </li>",
"     <li>",
"      A mediastinal mass which has a maximum width equal to or greater than one-third of the internal transverse diameter of the thorax (at the pleural surfaces) at the level of",
"      <span class=\"nowrap\">",
"       T5/6",
"      </span>",
"      as determined on a posteroanterior chest radiograph. The",
"      <span class=\"nowrap\">",
"       T5/6",
"      </span>",
"      criteria are used in an attempt to create a consistent, reliable, and therefore reproducible measurement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A mediastinal mass noted on CT scan that is either 10 cm or greater or greater than one-third the internal transverse diameter of the thorax should qualify for bulky disease if a chest radiograph is not performed. However, an upright chest radiograph is the preferred modality for determining mediastinal bulky disease. Patient positioning, upright for the chest radiograph and supine for the CT scan, may create some differences between the measurements when both imaging modalities are used. For practical reasons, either criterion is acceptable. Lesions in the liver or spleen are not measured as part of the determination of bulky disease.",
"   </p>",
"   <p>",
"    Other definitions of bulk disease have been used to define patients with a worse prognosis, using cutoffs of 6 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] and 5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/11\">",
"     11",
"    </a>",
"    ]. In the Stanford V protocol, bulky disease, defined as 5 cm or greater, required the use of involved field irradiation following completion of chemotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10711?source=see_link&amp;anchor=H7#H7\">",
"     \"Definition of favorable and unfavorable prognosis early (stage I-II) classical Hodgkin lymphoma\", section on 'Large mediastinal adenopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Criteria for extranodal spread",
"    </span>",
"    &nbsp;&mdash;&nbsp;The designation \"E\" refers to extranodal contiguous extension (ie, proximal or contiguous extranodal disease) of HL that can be encompassed within an irradiation field appropriate for nodal disease of the same anatomic extent. Limited extranodal extension is defined by one of the following two criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Involvement of extralymphatic tissue on one side of the diaphragm by limited direct extension from an adjacent nodal site.",
"     </li>",
"     <li>",
"      An apparently discrete single extranodal deposit consistent with extension from a regionally involved node. If a single extralymphatic site is the only site of disease, the staging should be classified as IE.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of a single site of extranodal extension (E) is not classified as disseminated disease with the implicit expectation of a prognosis equivalent to that for treatment of nodal disease of the same anatomical extent. As an example, anterior extension of a mediastinal mass into the sternum or chest wall or extension to lung or pericardium should be recorded as extranodal extension. Diffuse or disseminated foci of involvement of one or more extralymphatic organs or tissues, with or without associated lymphatic involvement is designated as stage IV disease.",
"   </p>",
"   <p>",
"    The importance of limited extranodal involvement was suggested by a retrospective study that found a striking difference in prognosis between patients with essentially localized extralymphatic organ involvement (contiguous with an involved lymph node region) and disseminated extralymphatic involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Subclassifying stage III disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Cotswolds modifications included a subclassification system for stage III disease based upon data that demonstrated a worse prognosis in patients with more extensive abdominal disease when treated with radiation therapy alone. However, this distinction has lost its utility since patients are no longer treated with irradiation alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     EXAMPLES OF STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following are provided as examples of the application of the Ann Arbor staging system with Cotswolds modifications:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An asymptomatic patient with bilateral cervical and right axillary lymph nodes with a small mediastinal mass would be staged as IIA disease.",
"     </li>",
"     <li>",
"      A symptomatic patient with night sweats, weight loss of 15 kg, bilateral cervical node enlargement, a mediastinal mass on the chest radiogram that is greater than one-third of the internal transverse diameter of the thorax at the level of",
"      <span class=\"nowrap\">",
"       T5/6",
"      </span>",
"      interspace, involvement of right hilum, an abdominal CT showing paraaortic and pelvic adenopathy with no definite involvement of the liver, and a negative bone marrow would be staged as IIIBX.",
"     </li>",
"     <li>",
"      A symptomatic patient with bone marrow involvement would be staged as IVB.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9398216\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have attempted to use prognostic factors to delineate a group of patients at high risk for first relapse and who might benefit from more intensive initial therapy. The strongest predictor of outcome that can be easily applied in the clinical setting is the International Prognostic Score (IPS). This is described in more detail in the section below. In addition, several prognostic schemes have been used in clinical trials to divided patients with localized disease into those with favorable risk and unfavorable risk disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9398231\">",
"    <span class=\"h2\">",
"     International Prognostic Score",
"    </span>",
"    &nbsp;&mdash;&nbsp;The International Prognostic Score (IPS) is a predictor of treatment outcome for patients with Hodgkin lymphoma calculated based upon the following seven potential unfavorable features at diagnosis (",
"    <a class=\"graphic graphic_table graphicRef76219 \" href=\"UTD.htm?11/50/12077\">",
"     table 2",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?4/32/4609?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Serum albumin &lt;4",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"     </li>",
"     <li>",
"      Hemoglobin &lt;10.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"     </li>",
"     <li>",
"      Male gender",
"     </li>",
"     <li>",
"      Age &gt;45 years",
"     </li>",
"     <li>",
"      Stage IV disease",
"     </li>",
"     <li>",
"      White blood cell count",
"      <span class=\"nowrap\">",
"       &ge;15,000/microL",
"      </span>",
"     </li>",
"     <li>",
"      Absolute lymphocyte count",
"      <span class=\"nowrap\">",
"       &lt;600/microL",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      &lt;8 percent of the total white blood cell count.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In this system, one point is given for each of the above characteristics present in the patient, for a total score ranging from zero to seven, representing increasing degrees of risk. When applied to an initial group of 5141 patients with Hodgkin lymphoma treated with combination chemotherapy with or without radiotherapy, event-free survival rates at five years, correlated with IPS as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      No factors &mdash; 84 percent (7 percent of patients)",
"     </li>",
"     <li>",
"      One factor &mdash; 77 percent (22 percent of patients)",
"     </li>",
"     <li>",
"      Two factors &mdash; 67 percent (29 percent of patients)",
"     </li>",
"     <li>",
"      Three factors &mdash; 60 percent (23 percent of patients)",
"     </li>",
"     <li>",
"      Four factors &mdash; 51 percent (12 percent of patients)",
"     </li>",
"     <li>",
"      Five or more factors &mdash; 42 percent (7 percent of patients)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Since the original publication of the IPS, outcomes of patients with advanced stage Hodgkin lymphoma treated with combination chemotherapy have gradually improved. A potentially more accurate prediction of freedom from progression (FFP) and overall survival (OS) in the modern era was provided by an analysis of 740 patients with advanced stage Hodgkin lymphoma treated with curative intent with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/49/4887?source=see_link\">",
"     dacarbazine",
"    </a>",
"    (ABVD) from 1980 to 2010 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/14\">",
"     14",
"    </a>",
"    ]. At a median follow-up of 77 months, FFP and OS at five years correlated with IPS as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      No factors &mdash; FFP 88 percent, OS 98 percent (8 percent of patients)",
"     </li>",
"     <li>",
"      One factor &mdash; FFP 84 percent, OS 97 percent (26 percent of patients)",
"     </li>",
"     <li>",
"      Two factors &mdash; FFP 80 percent, OS 91 percent (26 percent of patients)",
"     </li>",
"     <li>",
"      Three factors &mdash; FFP 74 percent, OS 88 percent (21 percent of patients)",
"     </li>",
"     <li>",
"      Four factors &mdash; FFP 67 percent, OS 85 percent (12 percent of patients)",
"     </li>",
"     <li>",
"      Five or more factors &mdash; FFP 62 percent, OS 67 percent (7 percent of patients)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This index has been validated in other cohorts and was also found to be valuable in predicting the outcome of patients with HL undergoing autologous hematopoietic cell transplantation (HCT) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14935/abstract/15\">",
"     15",
"    </a>",
"    ]. Estimated 10-year event-free survival rates after HCT were 38, 23, and 7 percent for subjects with 0 to 1, 2 to 3, or &ge;4 adverse factors, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9398983\">",
"    <span class=\"h2\">",
"     Favorable or unfavorable risk early stage disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stratification of patients with early stage disease into favorable and unfavorable subsets varies by region. In the United States, most centers define early stage favorable HL as non-bulky (&lt;10cm) stage IA-IIA disease. In contrast, European research organizations incorporate other variables such as patient age and the erythrocyte sedimentation rate (ESR). This is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10711?source=see_link&amp;anchor=H5#H5\">",
"     \"Definition of favorable and unfavorable prognosis early (stage I-II) classical Hodgkin lymphoma\", section on 'Favorable versus unfavorable disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/37/13908?source=see_link\">",
"       \"Patient information: Hodgkin lymphoma in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with Hodgkin lymphoma are staged according to the Ann Arbor staging system with Cotswolds modifications most frequently based upon information gathered from a history, physical examination, chest radiograph, and integrated positron emission",
"      <span class=\"nowrap\">",
"       tomography/computed",
"      </span>",
"      tomography",
"      <span class=\"nowrap\">",
"       (PET/CT)",
"      </span>",
"      scan of the chest, abdomen, and pelvis. A unilateral bone marrow aspirate and biopsy is performed for patients with stage III or IV disease and those with systemic B symptoms. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Staging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients are placed into one of four stages, based upon the sites of involvement, and are assigned numbers and letters that designate the number of nodes involved and the presence or absence of systemic symptoms or of bulky or extended disease (",
"      <a class=\"graphic graphic_table graphicRef66651 \" href=\"UTD.htm?19/23/19836\">",
"       table 1",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"local\" href=\"#H5\">",
"       'Determining organ involvement'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Stage I &mdash; Involvement of a single lymph node region (I) or of a single extralymphatic organ or site (IE).",
"     </li>",
"     <li>",
"      Stage II &mdash; Involvement of two or more lymph node regions on the same side of the diaphragm alone (II) or with involvement of limited, contiguous extralymphatic organ or tissue (IIE). The number of anatomic regions should be indicated by a subscript (eg, II-3).",
"     </li>",
"     <li>",
"      Stage III &mdash; Involvement of lymph node regions or lymphoid structures on both sides of the diaphragm (III) which may include the spleen (IIIS) or limited, a contiguous extralymphatic organ or site (IIIE) or both (IIIES). This may be subdivided into stage III-1 or III-2: stage III-1 is used for patients with involvement of the spleen or splenic hilar, celiac or portal nodes; and stage III-2 is used for patients with involvement of the paraaortic, iliac, inguinal, or mesenteric nodes.",
"     </li>",
"     <li>",
"      Stage IV &mdash; Diffuse or disseminated foci of involvement of one or more extralymphatic organs or tissues, with or without associated lymphatic involvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All cases are subclassified to indicate the absence (A) or presence (B) of one or more of the following three systemic symptoms: significant unexplained fever, night sweats, or unexplained weight loss exceeding 10 percent of body weight during the six months prior to diagnosis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Criteria for B symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The subscript \"X\" is used if bulky disease is present. No subscripts are used in the absence of bulk. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Criteria for bulky disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The subscript \"E\" is used if limited extranodal extension is documented. More extensive extranodal disease is designated stage IV. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Criteria for extranodal spread'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with stage I or stage II disease are then further stratified for treatment purposes into favorable and unfavorable prognosis disease based upon the presence or absence of certain clinical features, such as age, B symptoms, and large mediastinal adenopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10711?source=see_link&amp;anchor=H5#H5\">",
"       \"Definition of favorable and unfavorable prognosis early (stage I-II) classical Hodgkin lymphoma\", section on 'Favorable versus unfavorable disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The International Prognostic Score (IPS) is the main prognostic tool used in more advanced Hodgkin lymphoma patients and incorporates information regarding patient age and gender, disease stage, and measurements of serum albumin, hemoglobin, white blood cell count, and absolute lymphocyte count (",
"      <a class=\"graphic graphic_table graphicRef76219 \" href=\"UTD.htm?11/50/12077\">",
"       table 2",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?4/32/4609?source=see_link\">",
"       calculator 1",
"      </a>",
"      ). This tool has been validated in the setting of initial treatment and in patients undergoing autologous hematopoietic cell transplantation for relapsed Hodgkin lymphoma. (See",
"      <a class=\"local\" href=\"#H9398231\">",
"       'International Prognostic Score'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/1\">",
"      Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31:1860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/2\">",
"      Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/3\">",
"      Advani RH, Horning SJ. Treatment of early-stage Hodgkin's disease. Semin Hematol 1999; 36:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/4\">",
"      Ng AK, Weeks JC, Mauch PM, Kuntz KM. Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease. J Clin Oncol 1999; 17:3577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/5\">",
"      Specht L. Prognostic Factors in Hodgkin's Disease. Semin Radiat Oncol 1996; 6:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/6\">",
"      Crnkovich MJ, Hoppe RT, Rosenberg SA. Stage IIB Hodgkin's disease: the Stanford experience. J Clin Oncol 1986; 4:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/7\">",
"      Crnkovich MJ, Leopold K, Hoppe RT, Mauch PM. Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy. J Clin Oncol 1987; 5:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/8\">",
"      Gobbi PG, Cavalli C, Gendarini A, et al. Reevaluation of prognostic significance of symptoms in Hodgkin's disease. Cancer 1985; 56:2874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/9\">",
"      Thar TL, Million RR, Hausner RJ, McKetty MH. Hodgkin's disease, stages I and II: relationship of recurrence to size of disease, radiation dose, and number of sites involved. Cancer 1979; 43:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/10\">",
"      Fabian CJ, Mansfield CM, Dahlberg S, et al. Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study. Ann Intern Med 1994; 120:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/11\">",
"      Bartlett NL, Rosenberg SA, Hoppe RT, et al. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. J Clin Oncol 1995; 13:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/12\">",
"      Musshoff K, Boutis L. Therapy results in Hodgkin's disease Freiburg i.Br., 1948-1966. Cancer 1968; 21:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/13\">",
"      Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998; 339:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/14\">",
"      Moccia AA, Donaldson J, Chhanabhai M, et al. International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era. J Clin Oncol 2012; 30:3383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14935/abstract/15\">",
"      Bierman PJ, Lynch JC, Bociek RG, et al. The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. Ann Oncol 2002; 13:1370.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4748 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-218.28.111.102-8C7B610DBC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14935=[""].join("\n");
var outline_f14_37_14935=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANN ARBOR STAGING SYSTEM WITH COTSWOLDS MODIFICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Overview of staging notation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Staging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Determining organ involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Spleen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Liver",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Lung",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Bone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Central nervous system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Other sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Criteria for B symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Criteria for bulky disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Criteria for extranodal spread",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Subclassifying stage III disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      EXAMPLES OF STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9398216\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9398231\">",
"      International Prognostic Score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9398983\">",
"      Favorable or unfavorable risk early stage disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4748\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4748|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/2/42021\" title=\"figure 1\">",
"      Lymph node regions lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4748|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/23/19836\" title=\"table 1\">",
"      Cotswolds system in HL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/50/12077\" title=\"table 2\">",
"      IPS Hodgkin lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?4/32/4609?source=related_link\" title=\"calculator 1\">",
"      Calculator: International Prognostic Score in Hodgkin Lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=related_link\">",
"      Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10711?source=related_link\">",
"      Definition of favorable and unfavorable prognosis early (stage I-II) classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15578?source=related_link\">",
"      Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29206?source=related_link\">",
"      Initial evaluation and diagnosis of Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13512?source=related_link\">",
"      Overview of the treatment of classical Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/37/13908?source=related_link\">",
"      Patient information: Hodgkin lymphoma in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_37_14936="Dermatomyositis - heliotrope eruption";
var content_f14_37_14936=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F56879%7EDERM%2F68649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F56879%7EDERM%2F68649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heliotrope eruption in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Violaceous erythema is present on the periorbital skin in this patient with dermatomyositis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatomyositis - heliotrope eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Violaceous erythema and edema is present on the upper eyelid in this patient with dermatomyositis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14936=[""].join("\n");
var outline_f14_37_14936=null;
var title_f14_37_14937="Evaluation of oligomenorrhea in adolescence";
var content_f14_37_14937=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of oligomenorrhea in adolescence",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/37/14937/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14937/contributors\">",
"     Jan Paradise, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/37/14937/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14937/contributors\">",
"     John L Kirkland, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14937/contributors\">",
"     Stephen J Teach, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/37/14937/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/37/14937/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/37/14937/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oligomenorrhea means infrequent menstruation. A menstrual cycle is defined as the number of days from the first day of one bleeding episode to the first day of the next bleeding episode. For the clinician evaluating an adolescent, oligomenorrhea can be defined as a menstrual cycle of longer than six weeks. The term secondary amenorrhea is applied if menstruation does not resume within three to six months. However, because of the chance that pregnancy could be the cause, clinicians evaluating adolescents must not dismiss brief delays in the onset of an expected menstrual period. Oligomenorrhea should be distinguished from hypomenorrhea, a nonpathologic pattern of light or short, but nonetheless regular menstrual periods.",
"   </p>",
"   <p>",
"    Some adolescents with anovulatory menstrual cycles have oligomenorrhea punctuated by episodes of excessive bleeding. An approach to the evaluation of excessive vaginal bleeding in adolescents is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/57/11160?source=see_link\">",
"     \"Differential diagnosis and approach to the adolescent with abnormal uterine bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Primary amenorrhea, that is, failure to menstruate by a specified age, often 15 years, and issues related to secondary amenorrhea or oligomenorrhea in adult women are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2089?source=see_link\">",
"     \"Etiology, diagnosis, and treatment of primary amenorrhea\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34697?source=see_link\">",
"     \"Etiology, diagnosis, and treatment of secondary amenorrhea\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3746857\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following definitions can provide clarity when considering whether or not a patient&rsquo;s menstrual pattern is abnormal:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Menstrual cycle &ndash; The number of days from the first day of one bleeding episode to the first day of the next bleeding episode",
"     </li>",
"     <li>",
"      Oligomenorrhea &ndash; Infrequent menstruation (menstrual cycle that is longer than six weeks)",
"     </li>",
"     <li>",
"      Primary amenorrhea &ndash; Failure to menstruate by a given age (typically 15 years)",
"     </li>",
"     <li>",
"      Secondary amenorrhea &ndash; Failure to resume menstruation within three months after the preceding period",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of oligomenorrhea in adolescents are given in the table (",
"    <a class=\"graphic graphic_table graphicRef71767 \" href=\"UTD.htm?21/0/21516\">",
"     table 1",
"    </a>",
"    ). Some of the listed disorders can produce primary amenorrhea as part of an overall delay in pubertal development rather than secondary amenorrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Life-threatening conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although oligomenorrhea is a common complaint among adolescents, the symptom indicates the presence of a life-threatening disorder only rarely. Ectopic pregnancy and anorexia nervosa are life-threatening conditions that can present with oligomenorrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Ectopic pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal pain and amenorrhea followed by vaginal bleeding are the classic presenting symptoms of ectopic pregnancy. Although approximately 98 percent of all pregnancies are intrauterine, and although ectopic pregnancy is more common in adult women than in adolescents between the ages of 15 and 24 years, nevertheless the diagnosis of ectopic pregnancy should be considered in the adolescent who presents with a missed menstrual period followed by vaginal bleeding or abdominal pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Anorexia nervosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oligomenorrhea is one of four criteria for the diagnosis of anorexia nervosa (",
"    <a class=\"graphic graphic_table graphicRef75110 \" href=\"UTD.htm?9/7/9339\">",
"     table 2",
"    </a>",
"    ) and is often one of the earliest symptoms of this condition. Life-threatening complications of anorexia nervosa include suicide, extreme bradycardia, hypotension, and cardiac conduction abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=see_link&amp;anchor=H31379357#H31379357\">",
"     \"Anorexia nervosa in adults and adolescents: Medical complications and their management\", section on 'Cardiovascular'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link&amp;anchor=H18369710#H18369710\">",
"     \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\", section on 'Mortality'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Common conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of oligomenorrhea in adolescents are physiologic variations in the timing of menstrual periods in young adolescents, pregnancy, contraception-related oligomenorrhea, polycystic ovary syndrome (PCOS), and caloric deprivation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Delayed maturation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Menstrual cycle length is most variable during the first few years after menarche (and again during the transition to menopause) (",
"    <a class=\"graphic graphic_figure graphicRef79925 \" href=\"UTD.htm?0/27/446\">",
"     figure 1",
"    </a>",
"    ). Accordingly, young adolescents are more likely than older ones to experience an unexpectedly long menstrual cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. But one cannot use chronologic age per se to judge whether or not a girl&rsquo;s menstrual pattern is normal, since chronologic age at menarche is influenced by maternal age at menarche [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/3\">",
"     3",
"    </a>",
"    ] and varies substantially by ethnicity. However, regardless of ethnicity, a girl&rsquo;s menstrual pattern should become regular within one or two years after menarche as indicated by several studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a World Health Organization study of Asian adolescents, 38 percent of the girls had a first menstrual cycle after menarche that lasted more than 40 days, but the proportion of cycles longer than 40 days fell to about 9 percent after 13 or more cycles [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In an older study, the proportion of Finnish girls with menstrual cycles longer than 60 days fell from 2.6 percent in the first year after menarche to 0.2 percent after girls had been menstruating for five years or longer [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 230 American 12 to 14-year-old girls, of whom half were African-American and half Caucasian, girls less than one year after menarche were more likely than those who had had menstrual periods for longer than one year to have a cycle longer than 45 days (odds ratio 1.44) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the fact that pregnancy rates in United States teenagers have declined substantially and nearly continuously since 1990 (",
"    <a class=\"graphic graphic_figure graphicRef78213 \" href=\"UTD.htm?8/62/9198\">",
"     figure 2",
"    </a>",
"    ), pregnancy remains a common cause of oligomenorrhea among adolescents that should be identified promptly. Pregnancy is much more common in older teenagers than younger ones, since a much higher proportion of older teenagers are sexually active [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/31/10744?source=see_link&amp;anchor=H2#H2\">",
"     \"Pregnancy in adolescents\", section on 'Scope of the problem'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Hormonal contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estrogen and progestin-containing contraceptive medications often cause oligomenorrhea. About 50 percent of women using injectable depot",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/49/36631?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    (Depo-Provera, DMPA) for contraception develop amenorrhea after one year of use. Many of the remainder have bleeding only once in three months, shortly before the next injection is due. There is a strong positive correlation between the duration of DMPA use and the prevalence of amenorrhea. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=see_link&amp;anchor=H10#H10\">",
"     \"Depot medroxyprogesterone acetate for contraception\", section on 'Menstrual changes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients using either an extended or a continuous oral contraceptive pill regimen (eg, brand names: Seasonale&copy;, Seasonique&copy;, and Lybrel&copy;) will of course have menstrual bleeding limited primarily to pill-free or hormone-free intervals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/47/3832?source=see_link\">",
"     \"Hormonal contraception for suppression of menstruation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Polycystic ovary syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polycystic ovary syndrome (PCOS, previously the Stein-Leventhal syndrome) is probably the most common cause of persistent oligomenorrhea in adolescents. Although hirsutism, obesity, ovarian enlargement, and amenorrhea or infertility constitute the classic features of the disorder, patients with PCOS are heterogeneous (",
"    <a class=\"graphic graphic_table graphicRef80095 \" href=\"UTD.htm?11/29/11740\">",
"     table 3",
"    </a>",
"    ). Most adolescents with clinical and biochemical evidence of PCOS do not have enlarged ovaries, and their hyperandrogenism is typically mild. Some teenagers present with oligomenorrhea as their sole clinical abnormality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and diagnosis of polycystic ovary syndrome in adolescents\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Caloric deprivation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Caloric deprivation from any cause (eg, malabsorptive diseases [eg, celiac disease, ulcerative colitis, Crohn&rsquo;s disease], chronic illness, eating disorders) can produce oligomenorrhea in adolescents. Oligomenorrhea has been observed in about one-third of adolescents with bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/8\">",
"     8",
"    </a>",
"    ] and is a common presenting symptom in girls with anorexia nervosa (",
"    <a class=\"graphic graphic_table graphicRef75110 \" href=\"UTD.htm?9/7/9339\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Anorexia nervosa'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=see_link&amp;anchor=H33#H33\">",
"     \"Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults\", section on 'Menstrual and reproductive issues'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=see_link&amp;anchor=H31379371#H31379371\">",
"     \"Anorexia nervosa in adults and adolescents: Medical complications and their management\", section on 'Gynecologic and reproductive'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oligomenorrhea is common in female athletes, particularly among those who participate in sports that put a premium on thinness, such as gymnastics, ballet, figure skating, and running. However, the condition is not physiologic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Its pathophysiology appears to reflect the impact of chronic energy deficit on the hypothalamus as mediated by the hormones leptin and ghrelin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36919?source=see_link&amp;anchor=H2#H2\">",
"     \"Amenorrhea and infertility associated with exercise\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If energy deficit and the concomitant ovarian suppression become chronic, the situation can lead to a loss of bone mass. This latter, more extreme constellation of findings (disordered eating, amenorrhea, and osteoporosis) is known as the female athlete triad.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Uncommon conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of uncommon conditions can cause oligomenorrhea in adolescents:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2629122\">",
"    <span class=\"h3\">",
"     Thyroid disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 20 percent of women with thyroid dysfunction have abnormal menstrual cycles. Although hypothyroidism has in the past been generally believed to produce oligomenorrhea and hyperthyroidism to produce metrorrhagia, the effect of thyroid dysfunction on bleeding pattern is not consistent. Either excessive bleeding or oligomenorrhea can be seen in the context of either hyper or hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical manifestations of hypothyroidism\", section on 'Reproductive abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2629129\">",
"    <span class=\"h3\">",
"     Premature ovarian insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature ovarian insufficiency in adolescents is most commonly either iatrogenic or associated with Turner syndrome. It can also be produced by autoimmune disease, the fragile X mental retardation 1 (FMR1) premutation allele, and a variety of other, rarer genetic or syndromic conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. A history of hot flashes, antineoplastic chemotherapy, pelvic irradiation, or autoimmune disease suggests premature ovarian insufficiency. Young women with premature ovarian insufficiency due to a sex chromosome abnormality may be phenotypically normal or exhibit only short stature if they have mosaicism rather than classic Turner syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\", section on 'Ovarian failure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/40/7817?source=see_link&amp;anchor=H79730714#H79730714\">",
"     \"Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)\", section on 'Accelerated follicle depletion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2629136\">",
"    <span class=\"h3\">",
"     Hyperprolactinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperprolactinemia should be considered both in adolescents with spontaneous or expressible galactorrhea and in those taking medications that block pituitary dopamine receptors or interfere in other ways with dopaminergic or serotoninergic central nervous system pathways, especially antipsychotic medications (",
"    <a class=\"graphic graphic_table graphicRef75914 \" href=\"UTD.htm?2/58/2988\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=see_link\">",
"     \"Causes of hyperprolactinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Breastfeeding is an obvious physiologic cause of prolactin secretion and oligomenorrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2629149\">",
"    <span class=\"h3\">",
"     Non-classic congenital adrenal hyperplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-classic (late onset) congenital adrenal hyperplasia is a rare cause of hyperandrogenism that is usually clinically indistinguishable from polycystic ovarian syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=see_link&amp;anchor=H8#H8\">",
"     \"Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\", section on 'Female reproduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2629161\">",
"    <span class=\"h3\">",
"     Adrenocortical tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenocortical tumors are rare in children apart from a cluster of cases in southern Brazil. Most tumors produce rapidly developing virilization (and accordingly, oligo-amenorrhea in post-menarcheal adolescent girls) either alone or in combination with Cushing's syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical presentation and evaluation of adrenocortical tumors\", section on 'Adrenocortical carcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2629168\">",
"    <span class=\"h3\">",
"     Pseudocyesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudocyesis is a rare cause of amenorrhea in women who believe that they are pregnant and who exhibit many presumptive symptoms and signs of pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19927?source=see_link&amp;anchor=H13130911#H13130911\">",
"     \"Pseudocyesis\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient's menstrual pattern, weight and physical activity, medications, and a review of her endocrinological and gastrointestinal symptoms and sexual history can help to discriminate among the various causes of oligomenorrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Critical symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syncope and abdominal pain are symptoms that can indicate a life-threatening cause of oligomenorrhea. Syncope can be produced by a cardiac arrhythmia, dehydration, hypovolemia (anorexia nervosa), or by hemorrhage (ruptured ectopic pregnancy). Abdominal pain in a patient with oligomenorrhea also raises the question of ectopic pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Pertinent symptoms",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Menstrual pattern &mdash; Oligomenorrhea beginning shortly after menarche and continuing unabated suggests polycystic ovary syndrome (PCOS). Recent onset of oligomenorrhea after an interval of normal menstrual function suggests pregnancy, a medication side effect, caloric deprivation from any cause, or thyroid disease.",
"     </li>",
"     <li>",
"      Weight and physical activity &mdash; Weight loss, especially in combination with a desire to lose more weight or obsessional food behaviors (marked avoidance of food, cooking for others but refusing to eat) raises the question of anorexia nervosa (",
"      <a class=\"graphic graphic_table graphicRef75110 \" href=\"UTD.htm?9/7/9339\">",
"       table 2",
"      </a>",
"      ). Weight gain or obesity points to the possibility of PCOS (",
"      <a class=\"graphic graphic_table graphicRef80095 \" href=\"UTD.htm?11/29/11740\">",
"       table 3",
"      </a>",
"      ) or hypothyroidism, but the specificity is low. Intense physical exercise or participation in a sport that emphasizes thinness suggests caloric deprivation or anorexia nervosa.",
"     </li>",
"     <li>",
"      Medications &mdash; Inquiries should focus on hormonal contraceptives, antineoplastic therapies, and medications known to produce hyperprolactinemia (",
"      <a class=\"graphic graphic_table graphicRef75914 \" href=\"UTD.htm?2/58/2988\">",
"       table 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Endocrinologic symptoms &mdash; A history of hot flashes or autoimmune endocrine disease suggests premature ovarian insufficiency. A history of galactorrhea strongly suggests hyperprolactinemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19254?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical manifestations and diagnosis of hyperprolactinemia\", section on 'Clinical presentation'",
"      </a>",
"      .) Hirsutism or severe acne suggests PCOS or adrenal disease. Changes in weight can point to thyroid disease, but the specificity is low.",
"     </li>",
"     <li>",
"      Gastrointestinal symptoms &mdash; Nausea",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vomiting suggest early pregnancy. Abdominal pain can suggest ectopic pregnancy. Significant gastrointestinal disease can lead to caloric deprivation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Sexual history",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest the following approach to obtaining a sexual history from the adolescent patient in order to protect her confidentiality and to maximize the likelihood that her responses will be truthful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Questions about whether an adolescent has had sexual intercourse should only be posed when the patient's parent or guardian is not present.",
"     </li>",
"     <li>",
"      The clinician should introduce these questions with both an assurance that she or he will protect the teenager's confidentiality and a mention of any exceptions to confidentiality. State and federal laws and regulations can limit confidentiality in specific circumstances such as pregnancy in a minor, suicidality, and situations in which the teenager is in the legal custody of a state agency [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/15-18\">",
"       15-18",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=see_link\">",
"       \"Consent in adolescent health care\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For every patient who has had sexual intercourse, questions should focus on the use of contraceptive methods and difficulty with contraceptive use (missed contraceptive pills, broken or unused condom, etc).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Critical signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tachycardia, bradycardia, an irregular pulse, hypotension, and pelvic or abdominal tenderness may be signs of a life-threatening cause of oligomenorrhea (anorexia nervosa or an ectopic pregnancy). Patients with hypovolemia must be recognized immediately. Volume resuscitation should be initiated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=see_link\">",
"     \"Assessment of perfusion in pediatric resuscitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=see_link&amp;anchor=H13#H13\">",
"     \"Hypovolemic shock in children: Initial evaluation and management\", section on 'Fluid resuscitation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Pertinent signs",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight and height &mdash; Body weight less than 85 percent of that expected for age and height or a body mass index lower than fifth percentile for age suggests anorexia nervosa or caloric deprivation from another cause. Because overweight is so prevalent and because many adolescents with polycystic ovary syndrome (PCOS) are not obese, obesity per se has no predictive value for PCOS [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/19\">",
"       19",
"      </a>",
"      ]. Short stature (especially adult height under about 62 inches) raises the question of chromosomally mediated gonadal dysgenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/20-22\">",
"       20-22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Skin &mdash; Hirsutism suggests either an ovarian or an adrenal source of hyperandrogenism. Family and ethnicity strongly influence body hair distribution and density in women. However, a large number of or an increase in hairs on the chin or sideburns, between the breasts, around the areolae, along the linea alba, or on the thighs probably indicates clinically significant hirsutism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link\">",
"       \"Evaluation of premenopausal women with hirsutism\"",
"      </a>",
"      .) Moderate to severe acne is very common in normal adolescents but also can suggest hyperandrogenism. In addition, acanthosis nigricans (generally associated with obesity and insulin resistance) raises the question of polycystic ovary syndrome.",
"     </li>",
"     <li>",
"      Thyroid gland &mdash; Enlargement of the thyroid gland can suggest pregnancy, hypothyroidism, or less commonly, hyperthyroidism.",
"     </li>",
"     <li>",
"      Galactorrhea &mdash; Patients with hyperprolactinemia can have symptomatic galactorrhea, asymptomatic galactorrhea, or no galactorrhea. For the adolescent patient, the examination for galactorrhea should be prefaced with a brief explanation of its purpose. The examiner exerts gentle pressure on the periareolar area of each breast in an effort to express fluid. If galactorrhea is found, pregnancy, medications, hypothyroidism, and prolactinoma should be considered.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Pelvic examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the causes of oligomenorrhea do not typically involve anatomic abnormalities of the pelvis, a complete pelvic examination is usually unnecessary. This approach is in contrast to",
"    <strong>",
"     primary",
"    </strong>",
"    amenorrhea, which often does involve anatomic pelvic anomalies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2089?source=see_link&amp;anchor=H15#H15\">",
"     \"Etiology, diagnosis, and treatment of primary amenorrhea\", section on 'Congenital anatomic lesions of the uterus and vagina'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inspection of the external genitalia suffices to identify genital area hirsutism and clitoromegaly.",
"     </li>",
"     <li>",
"      Certain clinical circumstances warrant specific consideration, as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients who have never had sexual intercourse &mdash; These patients need not undergo either speculum or bimanual examination unless a pelvic mass is suspected. If a pelvic mass is suspected, then pelvic or rectal bimanual examination can be helpful.",
"     </li>",
"     <li>",
"      Patients with suspected polycystic ovary syndrome (PCOS) &mdash; Speculum and bimanual pelvic examinations are not helpful for the diagnosis of PCOS.&nbsp;Many adolescent patients with PCOS do not have enlarged ovaries even on ultrasound [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/19\">",
"       19",
"      </a>",
"      ], and if the ovaries are polycystic, this finding nevertheless has limited diagnostic usefulness [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/23,24\">",
"       23,24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with suspected pregnancy &mdash; Since office-based urine pregnancy testing is quick, sensitive, and specific, speculum and bimanual examinations are rarely needed to address the question of possible pregnancy.&nbsp;If bimanual examination is performed, cervical motion tenderness or adnexal tenderness suggests an ectopic location of the pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H8965674#H8965674\">",
"       \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Findings on physical examination'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H8967182#H8967182\">",
"       \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Urine pregnancy test'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with suspected abnormal or ectopic pregnancy &mdash; Speculum examination can point to the diagnosis of spontaneous abortion if tissue is seen at the cervix or in the vagina. In one large prospective study of women with clinically suspected ectopic pregnancy, bimanual pelvic examination did not add substantial diagnostic value beyond that afforded by abdominal and speculum examination, serum hCG measurement, and transvaginal ultrasonography [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/25\">",
"       25",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\", section on 'Physical examination'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Diagnostic evaluation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Pregnancy test",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a rule, every adolescent with oligomenorrhea should have a pregnancy test. Qualitative urine pregnancy tests performed in medical settings are highly sensitive for the detection of a normal pregnancy within about 10 days after conception and in most but not all cases, by the time an expected menstrual period is missed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H8967182#H8967182\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Urine pregnancy test'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients may report the result of a home pregnancy test. However, because of variability in patients' timing of ovulation and of blastocyst implantation, and because of variability in the tests' sensitivity for detecting urinary hCG, home pregnancy test kits commonly give falsely-negative results. Accordingly, the clinician should not rely on the reported result of a home pregnancy test to exclude the diagnosis of pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Home pregnancy test'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Endocrinologic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The selection of endocrinological laboratory tests should be guided by findings from the patient's history and physical examination (see",
"    <a class=\"local\" href=\"#H26\">",
"     'Algorithmic approach'",
"    </a>",
"    below). In the patient whose history and physical examination provide little direction, testing should explore the possibilities of hyperprolactinemia and of thyroid, adrenal, and ovarian disease.",
"   </p>",
"   <p>",
"    Oral progestin challenge is sometimes recommended as an in vivo test of ovarian and endometrial function. But the test can produce false positives: although the presence of bleeding after oral progestin challenge is thought to demonstrate normal ovarian function, nearly 50 percent of women with premature ovarian insufficiency also show withdrawal bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/26\">",
"     26",
"    </a>",
"    ]. In addition, since nearly all nonpregnant adolescents with oligomenorrhea have some ovarian estrogen present and will have withdrawal bleeding, establishing a specific diagnosis will still necessitate laboratory testing. Thus, for adolescents with oligomenorrhea, interposing a progestin challenge merely postpones the laboratory evaluation that must be undertaken in order to establish a diagnosis and to select an appropriate treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic ultrasound must be performed on all pregnant patients with abdominal or pelvic pain to exclude ectopic pregnancy or other complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\", section on 'Diagnostic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, pelvic imaging to identify a possible ovarian or adrenal tumor is warranted for patients with rapidly progressive virilization or an abdominal or pelvic mass. Although the identification of polycystic ovaries on ultrasounds fulfills one of the Rotterdam or Androgen Excess Society criteria for the diagnosis of polycystic ovarian syndrome PCOS (",
"    <a class=\"graphic graphic_table graphicRef80095 \" href=\"UTD.htm?11/29/11740\">",
"     table 3",
"    </a>",
"    ), the test has poor predictive value [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/19,23,24,27\">",
"     19,23,24,27",
"    </a>",
"    ]. Furthermore, for the patient whose presenting problem is oligomenorrhea, demonstration of either clinical or biochemical evidence of hyperandrogenism suffices to establish the diagnosis of PCOS. Accordingly, most experts do not consider pelvic ultrasonography (or any other imaging) necessary to establish the diagnosis of PCOS in most cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     ALGORITHMIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following discussion and associated algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef54670 \" href=\"UTD.htm?11/4/11328\">",
"     algorithm 1",
"    </a>",
"    ) summarize a diagnostic approach for the adolescent with one or several missed menstrual periods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Pregnant patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;\"Is she pregnant?\" is the first question to answer. Prompt diagnosis and referral are crucial for the pregnant teenager who intends to continue her pregnancy or to seek a therapeutic abortion.",
"   </p>",
"   <p>",
"    Early and regular prenatal care is associated with reduced morbidity and mortality among pregnant teenagers and their offspring. Early diagnosis affords the pregnant adolescent more time to decide on and arrange for a therapeutic abortion, if that is her choice. In many US states, an adolescent under the age of 18 years who desires therapeutic abortion is required to notify one or both parents or to obtain either parental or judicial consent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/28\">",
"     28",
"    </a>",
"    ]. This extra time needed for notification or consent could push the procedure into the second trimester, resulting in higher morbidity and higher cost.",
"   </p>",
"   <p>",
"    The diagnoses of ectopic pregnancy and spontaneous abortion must be entertained in a patient with one or several missed menstrual periods who complains of abdominal pain or abnormal vaginal bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15465?source=see_link\">",
"     \"Overview of the etiology and evaluation of vaginal bleeding in pregnant women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pseudocyesis is a rare cause of amenorrhea in women who believe they are pregnant and who exhibit many presumptive symptoms and signs of pregnancy, including nausea, vomiting, hyperpigmented areolae, galactorrhea, and abdominal distension. The diagnosis is made when a patient who insists that she is pregnant nevertheless has no true uterine enlargement, no demonstrable fetal parts or heart sounds, and a negative pregnancy test. Psychiatric consultation should be obtained for such patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19927?source=see_link&amp;anchor=H13130953#H13130953\">",
"     \"Pseudocyesis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Nonpregnant patients",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     With diagnostic clues on clinical evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;After pregnancy has been excluded, some oligomenorrheic patients will have findings that strongly suggest a particular diagnosis. Thyroid disease should be excluded in all of these patients because the symptoms can be protean. Otherwise, further clinical and laboratory evaluation can focus on the evident problem. Specific conditions include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Caloric deprivation &mdash; Caloric deprivation is the most likely cause of oligomenorrhea in patients who exercise intensively and those with symptoms or signs characteristic of anorexia nervosa (",
"      <a class=\"graphic graphic_table graphicRef75110 \" href=\"UTD.htm?9/7/9339\">",
"       table 2",
"      </a>",
"      ), bulimia nervosa, or serious chronic illness. Exhaustive laboratory evaluation is unnecessary for such patients if they have no findings to suggest an alternative diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36919?source=see_link\">",
"       \"Amenorrhea and infertility associated with exercise\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Depot",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/49/36631?source=see_link\">",
"       medroxyprogesterone acetate",
"      </a>",
"      (DMPA) &mdash; This contraceptive method causes oligomenorrhea in many users. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Causes'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=see_link&amp;anchor=H10#H10\">",
"       \"Depot medroxyprogesterone acetate for contraception\", section on 'Menstrual changes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Antineoplastic therapy &mdash; Among antineoplastic treatments, alkylating agents (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/62/38886?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      , cisplatinum,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/19/7479?source=see_link\">",
"       busulfan",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/59/39862?source=see_link\">",
"       procarbazine",
"      </a>",
"      ) and spinal or pelvic irradiation are most likely to produce ovarian damage or insufficiency. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1447?source=see_link&amp;anchor=H2#H2\">",
"       \"Ovarian failure due to anticancer drugs and radiation\", section on 'Chemotherapeutic drugs'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1447?source=see_link&amp;anchor=H3#H3\">",
"       \"Ovarian failure due to anticancer drugs and radiation\", section on 'Radiation therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Galactorrhea &mdash; Laboratory evaluation can be simple for patients who have galactorrhea",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      are taking one of the medications listed in the table (",
"      <a class=\"graphic graphic_table graphicRef75914 \" href=\"UTD.htm?2/58/2988\">",
"       table 4",
"      </a>",
"      ). A prolactin level should be measured. Medications generally produce only a mild elevation. A very high level suggests pituitary adenoma [",
"      <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/29\">",
"       29",
"      </a>",
"      ]. If the prolactin level is normal, evaluation for alternative causes of oligomenorrhea with galactorrhea should be pursued. Hypothyroidism specifically should be excluded because, rarely, hypothalamic thyroid-releasing hormone acts as a prolactin-releasing factor, resulting in galactorrhea",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      oligomenorrhea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=see_link\">",
"       \"Causes of hyperprolactinemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Marked virilization or Cushing's syndrome &mdash; Evaluation should focus on the possibility of adrenal disease in patients who abruptly develop marked hirsutism, acne,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      clitoromegaly, with or without signs of Cushing's syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link&amp;anchor=H2#H2\">",
"       \"Evaluation of premenopausal women with hirsutism\", section on 'Evaluation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Without diagnostic clues on clinical evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An oligomenorrheic adolescent who is fewer than two years past menarche, is not sexually active, and has no symptoms or signs to suggest a specific cause of oligomenorrhea may simply have delayed maturation. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Delayed maturation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If delayed maturation seems likely, it is reasonable to postpone further investigation at least for a few months. However, the prognosis for such adolescents is guarded, and they should be followed. Biochemical evidence of hyperandrogenism has been observed in some adolescents with no clinical signs of hyperandrogenism but with oligomenorrhea within the first three years after menarche [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/30\">",
"     30",
"    </a>",
"    ]. In a prospective study of adolescents&rsquo; menstrual patterns, 51 percent of 14 to 16-year-old girls with oligomenorrhea at enrollment remained oligomenorrheic after three years of follow-up, as compared with only 2 percent of age-matched adolescents whose menstrual cycles at enrollment were normal [",
"    <a class=\"abstract\" href=\"UTD.htm?14/37/14937/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most often, the oligomenorrheic adolescent is more than two years after menarche, and her history and examination offer few clues to diagnosis or only findings with low predictive value (eg, obesity, short stature, acne). In this situation, she should undergo laboratory evaluation for the range of conditions that can produce oligomenorrhea.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An elevated prolactin level suggests a pituitary adenoma in patients who are not using any of the drugs known to cause hyperprolactinemia and galactorrhea (",
"      <a class=\"graphic graphic_table graphicRef75914 \" href=\"UTD.htm?2/58/2988\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=see_link&amp;anchor=H7#H7\">",
"       \"Causes of hyperprolactinemia\", section on 'Lactotroph adenomas'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Thyroid-stimulating hormone should be measured to identify patients with thyroid disease either as the cause of oligomenorrhea or as a concomitant condition. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical manifestations of hypothyroidism\", section on 'Reproductive abnormalities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A follicle-stimulating hormone level elevated into the menopausal range suggests premature ovarian insufficiency. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36903?source=see_link\">",
"       \"Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A mildly elevated level of total or free testosterone or of dehydroepiandrosterone sulfate (DHEAS) fulfills one of the criteria for the diagnosis of polycystic ovary syndrome (PCOS) (",
"      <a class=\"graphic graphic_table graphicRef80095 \" href=\"UTD.htm?11/29/11740\">",
"       table 3",
"      </a>",
"      ). Many patients with PCOS have a normal total testosterone, but an elevated free testosterone level because their sex hormone-binding globulin level is decreased. A total testosterone level greater than 150",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (5.2",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      or a DHEAS level greater than 700",
"      <span class=\"nowrap\">",
"       mcg/dL",
"      </span>",
"      (13.6",
"      <span class=\"nowrap\">",
"       micromol/L)",
"      </span>",
"      suggests an adrenal tumor. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link&amp;anchor=H10#H10\">",
"       \"Evaluation of premenopausal women with hirsutism\", section on 'Biochemical testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A baseline 17-hydroxyprogesterone serum level drawn between 7:00 and 9:00 AM during the follicular phase of the menstrual cycle (ie, between cycle days 1 and 14, before ovulation) is the initial screening test for non-classic congenital adrenal hyperplasia. A normal level excludes the diagnosis. Patients with elevated baseline levels warrant",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/33/14871?source=see_link\">",
"       adrenocorticotropic hormone",
"      </a>",
"      provocative testing. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/21/1367?source=see_link&amp;anchor=H4#H4\">",
"       \"Diagnosis and treatment of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\", section on 'Nonclassic CYP21A2 deficiency'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with no identified laboratory abnormalities, negative energy balance with inadequate caloric intake from any cause, but especially chronic disease or disordered eating in association with intense exercise, is the most likely explanation for oligomenorrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oligomenorrhea means infrequent menstruation and is practically defined as a menstrual cycle that is longer than six weeks. (See",
"      <a class=\"local\" href=\"#H3746857\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oligomenorrhea is a commonly encountered complaint among adolescents. The most prevalent causes, apart from physiologic variations in the timing of menstrual periods shortly after menarche, are pregnancy, polycystic ovary syndrome (PCOS), medications, and caloric deprivation. Ectopic pregnancy and anorexia nervosa are life-threatening causes of oligomenorrhea. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinician evaluating an oligomenorrheic adolescent must begin by establishing whether or not she is pregnant. The history and physical examination will provide clues to the correct diagnosis in some nonpregnant adolescents with oligomenorrhea. However, most nonpregnant patients will require laboratory evaluation to establish a diagnosis. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with no identified laboratory abnormalities, negative energy balance with inadequate caloric intake from any cause, but especially chronic disease or disordered eating in association with intense exercise, is the most likely explanation for oligomenorrhea. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Without diagnostic clues on clinical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The algorithm provides an approach to the evaluation of the adolescent with oligomenorrhea (",
"      <a class=\"graphic graphic_algorithm graphicRef54670 \" href=\"UTD.htm?11/4/11328\">",
"       algorithm 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/1\">",
"      Adams Hillard PJ. Menstruation in adolescents: what's normal, what's not. Ann N Y Acad Sci 2008; 1135:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/2\">",
"      Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev 1995; 17:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/3\">",
"      Widholm O, Kantero RL. A statistical analysis of the menstrual patterns of 8,000 Finnish girls and their mothers. Acta Obstet Gynecol Scand Suppl 1971; 14:Suppl 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/4\">",
"      World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. World Health Organization Task Force on Adolescent Reproductive Health. J Adolesc Health Care 1986; 7:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/5\">",
"      Widholm O, Kantero RL. A statistical analysis of the menstrual patterns of 8,000 Finnish girls and their mothers. Acta Obstet Gynecol Scand Suppl 1971; 14:Suppl 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/6\">",
"      Harlow SD, Campbell B, Lin X, Raz J. Ethnic differences in the length of the menstrual cycle during the postmenarcheal period. Am J Epidemiol 1997; 146:572.",
"     </a>",
"    </li>",
"    <li>",
"     file://guttmacherinstitute.org/pubs/FB-ATSRH.pdf (Accessed on September 07, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/8\">",
"      le Grange D, Loeb KL, Van Orman S, Jellar CC. Bulimia nervosa in adolescents: a disorder in evolution? Arch Pediatr Adolesc Med 2004; 158:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/9\">",
"      Warren MP, Perlroth NE. The effects of intense exercise on the female reproductive system. J Endocrinol 2001; 170:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/10\">",
"      Stafford DE. Altered hypothalamic-pituitary-ovarian axis function in young female athletes: implications and recommendations for management. Treat Endocrinol 2005; 4:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/11\">",
"      Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000; 74:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/12\">",
"      Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/13\">",
"      Cameron M, Grover S, Moore P, Jayasinghe Y. Non-chromosomal, non-iatrogenic premature ovarian failure in an adolescent population: a case series. J Pediatr Adolesc Gynecol 2008; 21:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/14\">",
"      De Caro JJ, Dominguez C, Sherman SL. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency. Ann N Y Acad Sci 2008; 1135:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/15\">",
"      Molin R, Palmer S. Consent and participation: ethical issues in the treatment of children in out-of-home care. Am J Orthopsychiatry 2005; 75:152.",
"     </a>",
"    </li>",
"    <li>",
"     Dailard, C, Richardson, CT. Teenagers' access to confidential reproductive health services. The Guttmacher Report on Public Policy 2005; Vol. 8, No. 4. file://www.guttmacher.org/pubs/tgr/08/4/gr080406.html (Accessed on July 02, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/17\">",
"      English A. Sexual and reproductive health care for adolescents: legal rights and policy challenges. Adolesc Med State Art Rev 2007; 18:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/18\">",
"      Berlan ED, Bravender T. Confidentiality, consent, and caring for the adolescent patient. Curr Opin Pediatr 2009; 21:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/19\">",
"      Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999; 51:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/20\">",
"      McDonough PG, Byrd JR, Tho PT, Mahesh VB. Phenotypic and cytogenetic findings in eighty-two patients with ovarian failure--changing trends. Fertil Steril 1977; 28:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/21\">",
"      Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004; 351:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/22\">",
"      Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: a study of 252 patients. Am J Obstet Gynecol 1981; 140:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/23\">",
"      van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 1997; 67:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/24\">",
"      Guzick DS. Polycystic ovary syndrome. Obstet Gynecol 2004; 103:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/25\">",
"      Mol BW, Hajenius PJ, Engelsbel S, et al. Should patients who are suspected of having an ectopic pregnancy undergo physical examination? Fertil Steril 1999; 71:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/26\">",
"      Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/27\">",
"      Pfeifer SM, Dayal M. Treatment of the adolescent patient with polycystic ovary syndrome. Obstet Gynecol Clin North Am 2003; 30:337.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. State policies in brief: Parental involvement in minors' abortions. Guttmacher Institute, New York 2010. file://www.guttmacher.org/statecenter/spibs/spib_PIMA.pdf (Accessed on July 02, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/29\">",
"      Cannav&ograve; S, Venturino M, Curt&ograve; L, et al. Clinical presentation and outcome of pituitary adenomas in teenagers. Clin Endocrinol (Oxf) 2003; 58:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/30\">",
"      Avvad CK, Holeuwerger R, Silva VC, et al. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol Endocrinol 2001; 15:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/37/14937/abstract/31\">",
"      van Hooff MH, Voorhorst FJ, Kaptein MB, et al. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod 2004; 19:383.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6461 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-89.32.226.102-BE3A184D40-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14937=[""].join("\n");
var outline_f14_37_14937=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3746857\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Life-threatening conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Anorexia nervosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Common conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Delayed maturation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Hormonal contraception",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Caloric deprivation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Uncommon conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2629122\">",
"      - Thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2629129\">",
"      - Premature ovarian insufficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2629136\">",
"      - Hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2629149\">",
"      - Non-classic congenital adrenal hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2629161\">",
"      - Adrenocortical tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2629168\">",
"      - Pseudocyesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Critical symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Pertinent symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Sexual history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Critical signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Pertinent signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Pelvic examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Pregnancy test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Endocrinologic evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      ALGORITHMIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Pregnant patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Nonpregnant patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - With diagnostic clues on clinical evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Without diagnostic clues on clinical evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/6461\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/6461|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?11/4/11328\" title=\"algorithm 1\">",
"      Algorithm Oligomenorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/6461|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/27/446\" title=\"figure 1\">",
"      Menstrual interval",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/62/9198\" title=\"figure 2\">",
"      Pregnancy birth and abortion rates in US teenagers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/6461|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/0/21516\" title=\"table 1\">",
"      Causes oligomenorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/7/9339\" title=\"table 2\">",
"      DSM-IV-TR diagnostic criteria for anorexia nervosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/29/11740\" title=\"table 3\">",
"      Dx criteria PCOS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/58/2988\" title=\"table 4\">",
"      Drugs cause hyperprolactinemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36919?source=related_link\">",
"      Amenorrhea and infertility associated with exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=related_link\">",
"      Anorexia nervosa in adults and adolescents: Medical complications and their management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=related_link\">",
"      Assessment of perfusion in pediatric resuscitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=related_link\">",
"      Causes of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=related_link\">",
"      Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=related_link\">",
"      Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=related_link\">",
"      Clinical manifestations and diagnosis of early pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19254?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36903?source=related_link\">",
"      Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=related_link\">",
"      Clinical manifestations, diagnosis, and management of ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=related_link\">",
"      Clinical presentation and evaluation of adrenocortical tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=related_link\">",
"      Consent in adolescent health care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=related_link\">",
"      Depot medroxyprogesterone acetate for contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/21/1367?source=related_link\">",
"      Diagnosis and treatment of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/57/11160?source=related_link\">",
"      Differential diagnosis and approach to the adolescent with abnormal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=related_link\">",
"      Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2089?source=related_link\">",
"      Etiology, diagnosis, and treatment of primary amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34697?source=related_link\">",
"      Etiology, diagnosis, and treatment of secondary amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=related_link\">",
"      Evaluation of premenopausal women with hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=related_link\">",
"      Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/47/3832?source=related_link\">",
"      Hormonal contraception for suppression of menstruation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=related_link\">",
"      Hypovolemic shock in children: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1447?source=related_link\">",
"      Ovarian failure due to anticancer drugs and radiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15465?source=related_link\">",
"      Overview of the etiology and evaluation of vaginal bleeding in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/40/7817?source=related_link\">",
"      Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=related_link\">",
"      Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/31/10744?source=related_link\">",
"      Pregnancy in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19927?source=related_link\">",
"      Pseudocyesis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_37_14938="Glycolipid inclusion bodies";
var content_f14_37_14938=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F54672%7ENEPH%2F75690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F54672%7ENEPH%2F75690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plastic embedded renal tissue demonstrating glycolipid inclusion bodies in distal tubules, with relative sparing of proximal tubules, and interstitial fibrosis (toluidine blue stain, original magnification X80)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine 2002; 81:122. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plastic embedded tissue showing in site deposition of glycolipid in glomerular podocytes (toluidine blue stain, original magnification X80)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 369px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine 2002; 81:122. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14938=[""].join("\n");
var outline_f14_37_14938=null;
var title_f14_37_14939="Nebulizer technique";
var content_f14_37_14939=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F71696&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F71696&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Technique for use of medication nebulizer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Place patient in a comfortable position (preferably sitting up or partially supine, since there is some risk of spillage if the patient is lying flat).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Assemble apparatus.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Add medication to nebulizer.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use a fill volume of 3 to 6 mL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Attach a&nbsp;compressor or a pressurized gas supply&nbsp;(eg, compressed air or oxygen) with a flow of 6 to 8 L/min.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Instruct patient to breathe through the mouth whether using a mask or mouthpiece. If using a mouthpiece, the patient can rest teeth on mouthpiece and close lips around it.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Encourage patient to breathe with a slow inspiratory flow and an occasional deep breath.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Periodically tap nebulizer to return impacted&nbsp;droplets to reservoir.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stop&nbsp;treatment when the nebulizer sputters despite tapping.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14939=[""].join("\n");
var outline_f14_37_14939=null;
var title_f14_37_14940="Diagnostic criteria for Sweet syndrome";
var content_f14_37_14940=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for Sweet syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Classical*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Abrupt onset of painful erythematous plaques or nodules",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Histopathologic evidence of a dense neutrophilic infiltrate without evidence of leukocytoclastic vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Pyrexia &gt;38&deg;C",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Association with an underlying hematologic or visceral malignancy, inflammatory disease, or pregnancy, or preceded by an upper respiratory or gastrointestinal infection or vaccination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Excellent response to treatment with systemic corticosteroids or potassium iodide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Abnormal laboratory values at presentation (three of four): erythrocyte sedimentation rate &gt;20 mm/hr; positive C-reactive protein; &gt;8,000 leukocytes; &gt;70 percent neutrophils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Drug-induced",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A. Abrupt onset of painful erythematous plaques or nodules",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B. Histopathologic evidence of a dense neutrophilic infiltrate without evidence of leukocytoclastic vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C. Pyrexia &gt;38&deg;C",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        D. Temporal relationship between drug ingestion and clinical presentation, or temporally-related recurrence after oral challenge",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. Temporally-related resolution of lesions after drug withdrawal or treatment with systemic corticosteroids",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The patients with malignancy-associated Sweet syndrome are included with the patients with classical Sweet syndrome in this list of diagnostic criteria.",
"    <div class=\"footnotes\">",
"     * The presence of both major criteria (1 and 2), and two of the four minor classical Sweet syndrome.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      All five criteria (A, B, C, D, and E) are required for the diagnosis of drug-induced Sweet syndrome.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996; 34:918. Table used with the permission for Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14940=[""].join("\n");
var outline_f14_37_14940=null;
var title_f14_37_14941="Diagnosis nodular masses I";
var content_f14_37_14941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F69807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F69807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of nodular soft tissue masses-I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Type of nodule",
"      </td>",
"      <td class=\"subtitle1\">",
"       Location",
"      </td>",
"      <td class=\"subtitle1\">",
"       Characteristic features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Noninflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Ganglia",
"      </td>",
"      <td>",
"       Doral wrists; any synovial-lined joint",
"      </td>",
"      <td>",
"       Globular, transilluminates, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Surfer's nodule",
"      </td>",
"      <td>",
"       Extensor surface of forelegs and feet",
"      </td>",
"      <td>",
"       Firm, ovoid, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Painter's bosses",
"      </td>",
"      <td>",
"       Extensor surface of forelegs",
"      </td>",
"      <td>",
"       Firm, ovoid, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Epidermoid cyst",
"      </td>",
"      <td>",
"       Volar surface of digits, web between digits",
"      </td>",
"      <td>",
"       Hard, round, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Epidermal inclusion cyst",
"      </td>",
"      <td>",
"       Volar aspect of the distal phalanx of the index or middle finger, or within the interdigital webs",
"      </td>",
"      <td>",
"       Soft, round, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Dorsal exostosis",
"      </td>",
"      <td>",
"       Palpable bony exostosis",
"      </td>",
"      <td>",
"       Hard, tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Herniation of anterior tibialis muscle",
"      </td>",
"      <td>",
"       Foreleg at anterior ankle",
"      </td>",
"      <td>",
"       Nodular swelling, accentuated by weightbearing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Tumors",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lipoma",
"      </td>",
"      <td>",
"       Trunk, arms, hips, thighs",
"      </td>",
"      <td>",
"       Soft, oval, painless, asymmetric",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fibroma",
"      </td>",
"      <td>",
"       Digits, other soft tissue, bone",
"      </td>",
"      <td>",
"       Soft to hard, nontender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Neuroma",
"      </td>",
"      <td>",
"       Skin, forefoot",
"      </td>",
"      <td>",
"       Rarely palpable, pain and paresthesia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Giant cell tumors",
"      </td>",
"      <td>",
"       Tendons, bone",
"      </td>",
"      <td>",
"       Variable pain, can be malignant",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Sarcoma",
"      </td>",
"      <td>",
"       Head, neck, trunk, extremities",
"      </td>",
"      <td>",
"       Well localized, nontender, movable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Sometimes inflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Rheumatoid nodules",
"      </td>",
"      <td>",
"       Bilateral, extensor joint surfaces of extremities",
"      </td>",
"      <td>",
"       Round/ovoid, firm, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Rheumatic fever nodules",
"      </td>",
"      <td>",
"       Over a bony surface or prominence, or near tendons",
"      </td>",
"      <td>",
"       &lt;1 cm, nontender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Pseudorheumatoid nodules",
"      </td>",
"      <td>",
"       Forelegs of infants and children",
"      </td>",
"      <td>",
"       Firm, nontender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tophi",
"      </td>",
"      <td>",
"       Bilateral, extensor joint surfaces of extremities",
"      </td>",
"      <td>",
"       Nontender, soft to firm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Periarticular dystrophic calcification",
"      </td>",
"      <td>",
"       Feet, elbow, other soft tissue",
"      </td>",
"      <td>",
"       Hard, linear, tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Heterotopic ossification",
"      </td>",
"      <td>",
"       Thigh, elbow",
"      </td>",
"      <td>",
"       Irregular, bony hard, tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Synovial cyst",
"      </td>",
"      <td>",
"       Hip, knee, elbow",
"      </td>",
"      <td>",
"       1 to 2 cm, tender, firm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cubital bursitis and antecubital cyst",
"      </td>",
"      <td>",
"       Antecubital and anteromedial border of elbow",
"      </td>",
"      <td>",
"       Soft to firm cystic swelling",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Xanthoma",
"      </td>",
"      <td>",
"       Over pressure points, extensor surfaces, or Achilles tendons",
"      </td>",
"      <td>",
"       Pinkish yellow papules; bilateral",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14941=[""].join("\n");
var outline_f14_37_14941=null;
var title_f14_37_14942="Smith-Lemli-Opitz syndrome";
var content_f14_37_14942=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71463&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71463&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Smith-Lemli-Opitz syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 423px; height: 342px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The effect of Smith-Lemli-Opitz syndrome on the biosynthesis of estriol by the fetalplacental unit A mutation of the enzyme C7-reductase in the fetus prevents the conversion of 7-dehydrocholesterol (DHC) to cholesterol. This blockade leads to impaired biosynthesis of estriol. Conversion of 7-DHC to cholesterol by the mother, who is a carrier of the mutation and is not affected, is not impaired.",
"    <div class=\"footnotes\">",
"     DHEAS: dehydroepiandrosterone sulfate.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14942=[""].join("\n");
var outline_f14_37_14942=null;
var title_f14_37_14943="Photomicrograph of urine sediment with white blood cells";
var content_f14_37_14943=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Photomicrograph of urine sediment with white blood cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    White blood cells in the urine sediment with nuclei and granular cytoplasm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Frances Andrus, BA, Victoria Hospital, London, Ontario.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_37_14943=[""].join("\n");
var outline_f14_37_14943=null;
